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ABSRACT 
 
Spinocerebellar ataxia type 28 (SCA28) is a neurodegenerative disorder characterized 
by unbalanced standing, gait incoordination, nystagmus, ophthalmoparesis and 
pyramidal signs. Several disease-causing mutations have been identified in the 
AFG3L2 gene. The encoded protein, AFG3L2, coassembles with paraplegin into 
multimeric complexes, called the m-AAA proteases, in the inner mitochondrial 
membrane. These complexes are crucial components of the mitochondrial protein 
quality control system and regulate mitochondrial morphology. 
The haploinsufficient Afg312 mouse recapitulates the features of SCA28 patients, 
displaying motor incoordination due to dark degeneration of Purkinje cells (PC-
DCD). This is a form of degeneration characterized by toxic levels of intracellular 
Ca
2+
and activation of calpains. Differently from other forms of SCA, where this 
phenomenon is associated to excitotoxicity, in the SCA28 mouse is unique since it 
originates from a mitochondrial dysfunction. 
We established, that Afg312-depleted mitochondria ineffectively buffer the evoked 
peaks of Ca
2+
.This enhances cytoplasmic Ca
2+
 levels in PC, thus triggering PC-DCD. 
We demonstrated that this defect is caused by the negative synergism between the 
mitochondrial network fragmentation and the altered trafficking of the organelles to 
PC dendrites. 
To determine the molecular mechanism that induces mitochondrial network 
fragmentation in the absence of AFG3L2, we studied the regulatory pathway 
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involved in mitochondrial dynamics. Previous work demonstrated that mitochondrial 
morphology alteration, in the absence of AFG3L2, is caused by an increased OMA1-
mediated OPA1 processing. Studying the regulatory pathway that drives OMA1 
activity, we discovered that AFG3L2 is deeply involved in this pathway. Full length 
OMA1 protein is 60 kD, while the proposed active form is 40kD. We identified 
AFG3L2 as the most important protease involved in OMA1 60/40 kD processing 
although, additional unknown protease(s) contribute to alternative pathway during 
stress conditions. 
We found that the absence of the m-AAA protease induces a striking accumulation of 
the 60 kD band and a reduction of the 40kD. To clarify the role of AFG3L2 in OMA1 
processing we performed co-immunoprecipitation experiments, which disclosed a 
physical-interaction between the two proteins. Interestingly, we were able to rescue 
OMA1 processing in Afg3l2 ko murine embryonic fibroblasts by overexpression of 
wild type AFG3L2, but not with the proteolytic inactive mutant (AFG3L2-E575Q).  
Moreover, we showed that OMA1 40kD form is a substrate of the the i-AAA 
protease demonstrating that the m-AAA proteases and the i-AAA proteases work 
coordinately in the regulation of OMA1. 
These data, besides disclosing the pathogenetic mechanism of SCA28, demonstrate 
for the first time the impact of defective mitochondrial Ca
2+
uptake on local Ca
2+
 
signaling in a physiopathological condition of the nervous system. We demonstrated 
that the altered Ca
2+
 homeostasis is caused by the mitochondrial network 
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fragmentation, via OPA1 over processing OMA1-mediated consequent to the absence 
of AFG3L2. 
Moreover, we demonstrated for the first time the fundamental role of the m-AAA and 
the i-AAA complexes in the regulation of OMA1 processing and confirming their 
fundamental role in mitochondrial dynamics. 
Abbreviations  
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ABBREVIATIONS 
 
AAA ATPase associated with a varietyof cellular activities 
AFG3L1 ATPase family gene 3 like -1 
AFG3L2 ATPase family gene 3 like -2 
AD Alzheimer's disease 
ALS Amyotrophic Lateral Sclerosis 
ATP Adenosine triphosphate 
Ca
2+
 Calcium 
CMT Charcot-Marie-Tooth disease 
CNS central nervous system 
CuZn-SOD copper-zinc superoxide dismutase 
DCD Dark cell degeneration 
DMSO dimethyl sulfoxide 
DOA Autosomal Dominant Optic Atrophy 
DRP dynamin-related protein  
EM electron microscopy 
FBS fetal bovine serum 
FCCP Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone 
HBSS Hank's Balanced Salt Solution (HBSS) 
HD Huntington's disease 
HRP Hereditary Spastic Paraplegia 
HSP 60 heat shock protein 60 
H202 hydrogen peroxide 
IMM inner mitochondrial membrane 
IMS intermembrane space 
kD kiloDalton  
ko knockout 
LTA large T antigen 
MEFs mouse embryonic fibroblasts 
MEM minimum essential medium 
MFN mitofusin 
mHSP 70 Mitochondrial heat shock protein 70 
MrpL32 mitochondrial ribosomal protein L32 
MS/ MS mass spectrometry/ mass spectrometry 
mtDNA mitochondrial DNA 
mtYFP mitochondrial yellow fluorescent protein 
MTS mitochondrial targeting sequence 
MW molecular weight 
OMA1 Overlapping m-AAA 
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OPA1 Optic Atrophy 1 
02
-
 superoxide radical ion 
PARL presenilin associated, rhomboid-like 
PBS phosphate buffered saline 
PCs Purkinje cell 
PCR polymerase chain reaction 
PIC protease inhibitor cocktail  
PD Parkinson's disease 
Phb prohibitin 
PNS peripheral nervous system 
PTP permeability-transition pore 
PTM Post translational modification 
QC quality control 
RC respiratory chain 
ROS reactive oxygen species 
RT Room temperature 
SCA spinocerebellar ataxia 
Scr Scrambled 
SD standard deviation 
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SPG7 Spastic Paraplegia 7 
SV40 Simian Virus 40 
TIM translocase of inner membrane 
TM transmembrane domain 
TOM translocase of outer membrane 
VDAC voltage-dependent anion channel 
WA Walker-A motif 
WB Walker-B motif 
Wt wild type 
YME1L1 YME1-Like 1 ATPase 
Δφ mitochondrial membrane potential 
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INTRODUCTION 
Role of mitochondria in neuronal cells 
 
Mitochondria are the central organelles for cell survival in fact, they are the primary 
generators of cellular energy by OXPHOS but also because in the last decades it has 
been demonstrated the pivotal role of these organelles in several cellular aspect. They 
play an important role in regulating calcium (Ca
2+
) homeostasis, in mediating amino 
acid biosynthesis, fatty acid oxidation, steroid metabolism, intermediate metabolic 
pathways and free radical scavenging. Moreover, mitochondria are integrated in a 
number of signaling pathways, including cell death cascades. Cells of highly 
metabolic tissues such as muscle, liver and brain, are therefore particularly dependent 
on mitochondria. 
The central nervous system (CNS) has an intense demand for mitochondria, which 
produce over 95% of ATP utilized by the brain. A cortical neuron in human brain 
utilizes up to ~ 4.7 billion ATP molecules per second to power various biological 
functions (Zhu et al., 2012). Constant ATP supply is essential for nerve cell survival 
and function (Nicholls and Budd, 2000). Mitochondrial ATP production supports 
synapse assembly (Lee and Peng, 2008), generation of action potentials (Attwell and 
Laughlin, 2001), and synaptic transmission (Verstreken et al., 2005). Synaptic 
mitochondria maintain and regulate neurotransmission by buffering Ca
2+
 (David and 
Barrett, 2003; Medler and Gleason, 2002). In addition, mitochondria sequester 
presynaptic Ca
2+ 
transients elicited by trains of action potentials and release Ca
2+
 after 
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stimulation, thus inducing certain forms of short-term synaptic plasticity (Kang et al., 
2008). Removing mitochondria axon terminals results in aberrant synaptic 
transmission likely due to insufficient ATP supply or altered Ca
2+ 
transients (Stowers 
et al., 2002) (Ma et al., 2009). Neurons are polarized cells consisting of a relatively 
small cell body, dendrites with multiple branches and elaborate arbors, and a thin 
axon that can extend up to a meter long in some peripheral nerves. Due to these 
extremely varied morphological features, neurons face exceptional challenges to 
maintain energy homeostasis. Neurons require specialized mechanisms to efficiently 
distribute mitochondria to far distal areas where energy is in high demand, such as 
synaptic terminals, active growth cones, and axonal branches (Fig. A) (Ruthel and 
Hollenbeck, 2003). Axonal branches and synapses undergo dynamic remodeling 
during neuronal development and in response to synaptic activity, thereby changing 
mitochondrial trafficking and distribution. Neurons are postmitotic cells surviving for 
the lifetime of the organism. A mitochondrion needs to be removed when it becomes 
aged or dysfunctional. Mitochondria also alter their motility and distribution under 
certain stress conditions or when their integrity is impaired (Cai et al., 2012). 
Therefore, efficient regulation of mitochondrial trafficking and anchoring is essential 
to: (1) recruit and redistribute mitochondria to meet altered metabolic requirements; 
and (2) remove aged and damaged mitochondria and replenish healthy ones at distal 
terminals.  
Compelling evidence is pointing the attention on altered mitochondrial trafficking as 
a potential contributor to diseases of the nervous system. Mitochondrial biogenesis 
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primarily takes place close to the nucleus in the cell body and subsequent distribution 
of mitochondria to regions where their functions are required occurs by organelle 
transport system. Mitochondrial trafficking is especially important in neurons, where 
regions with high demands for mitochondrial functions often are localized at a great 
distance from the cell body in axonal ends and synapses (Hollenbeck, 1996). 
Mitochondria are also required at active growth cones (Morris and Hollenbeck, 
1993), at nodes of Ranvier and at myelination/demyelination interfaces (Bristow et 
al., 2002). Fast axonal transport requires microtubule networks constructed by 
parallel microtubule polymers with the (+)-end directed towards the axon terminals. 
Kinesin motor proteins (KIF5) bind to mitochondria via anchor proteins and drive the 
anterograde-directed transport (towards axon terminals) whereas motor proteins of 
the dynein family drive transport of mitochondria in the retrograde direction towards 
the cell body. Mitochondrial transport can also take place on actin microfilaments 
using myosin motor proteins in more short-range transport processes (Saxton and 
Hollenbeck, 2012). Axonal transport involves coordinated frequent start and stop 
motions and switch between anterograde and retrograde movements, which are 
regulated by physiological events and intracellular signals (Miller and Sheetz, 2004). 
The average velocity of mitochondrial transport falls between that of fast-moving 
small vesicles and slow-moving cytoskeletal proteins (Saxton and Hollenbeck, 2012).  
Mitochondria with high mitochondrial membrane potential (Δφm), indicative of 
metabolically active mitochondria, preferentially move from the cell body towards 
the axon ends, whereas 80% of the mitochondria with low potential, indicative of 
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dysfunctional mitochondria move toward the cell body (Miller and Sheetz, 2004). 
This suggests that dysfunctional mitochondria are transported back to the cell body 
where replenishing of mitochondria with new proteins can restore their functionality. 
Disturbance of axonal transport has been linked to axonal degeneration in spastic 
paraplegia by the discovery that some of the mutated genes in hereditary forms of the 
disease encode proteins with known or putative roles in axonal transport (e.g. the 
kinesin gene ICIF5A) (Ankarcrona et al., 1995).  
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Figure A: Mitochondrial trafficking and anchoring in neurons. 
 
 
 
 
Due to complex structural features, neurons require specialized mechanisms trafficking mitochondria 
to their distal destinations and anchoring them in regions where metabolic and calcium homeostatic 
capacity is in a high demand. The figure highlights transporting mitochondria to a presynaptic bouton 
(A) and an axonal terminal (B). MT-based long-distance mitochondrial transport relies on MT polarity. 
In axons, the MT’s plus ends (+) are oriented toward axonal terminals whereas minus ends (−) are 
directed toward the soma. Thus, KIF5 motors are responsible for anterograde transport to distal 
synaptic terminals whereas dynein motors return mitochondria to the soma. 
Picure adapted from (Sheng and Cai, 2012)   
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Mitochondrial dysfunction and neurodegeneration 
 
Mitochondrial function and delivery are critical for neuronal health. It is therefore 
expected that disturbances of mitochondrial function and trafficking result in severe 
cellular damage and contribute to pathophysiology of several neurodegenerative 
disorders. The principal causes of degeneration can be linked to ATP depletion, 
dysregulation of Ca
2+
 homeostasis or reactive oxygen species (ROS) production. 
ATP depletion can induce necrotic cell death when insufficiently compensated by 
glycolytic ATP synthesis. In fact, ATP levels are an important determinant of 
whether cells die by apoptosis or necrosis, as ATP is required for events preceding 
apoptotic cell death such as apoptosome formation and caspase activation. 
Moreover, Mitochondrial ATP production supports many important functions, 
including the mobilization of synaptic vesicles for exocytosis and recycling (Gunter 
et al., 2004), the assembly of the actin cytoskeleton for presynaptic  development 
(Bonior et al., 2006) and the generation of axonal and synaptic  membrane potentials 
(Sheng and Cai, 2012) 
In addition, mitochondria have a tremendous capacity to sequester Ca
2+
 transients 
elicited by brief trains of action potentials (Lin and Beal, 2006). During neuronal 
stimulation, synaptic mitochondria maintain  Ca
2+
 homeostasis by buffering extra 
intracellular Ca
2+
 and releasing Ca
2+
  after stimulation to prolong the  residual Ca
2+
 
levels (Kwong et al., 2006). Through this mechanism, synaptic  mitochondria are 
thought to be involved in maintaining  and regulating neurotransmission  (Baloh et 
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al., 2007; Chang and Reynolds, 2006) or certain types of  short-term synaptic 
plasticity  (Sheng and Cai, 2012). Mitochondria regulate intracellular Ca
2+
 
concentrations ([Ca
2+
]i) in concert with the sarco-endoplasmic reticulum Ca
2+
-ATPase 
and the plasma membrane Ca
2+
-ATPase and Na
+
/ Ca
2+
  exchanger (Saris and 
Carafoli, 2005). In particular, mitochondrial Ca
2+
 uptake becomes important at [Ca
2+
] 
above 400-500 nM. Mitochondria are able to buffer [Ca
2+
] by virtue of their 
negatively charged mitochondrial membrane potential and low [Ca
2+
]mito relative to 
the [Ca
2+
]. Uptake of Ca
2+
 into the mitochondrial matrix is therefore 
electrochemically favored, and is largely accomplished through the Ca
2+
 -uniporter. 
Mitochondrial Ca
2+
 sequestration is reversible, with Ca
2+
 efflux back into the cytosol 
occurring through the mitochondrial Na
+
/ Ca
2+
 exchanger or, in case of pathological 
accumulation, through non-specific channels in the inner mitochondrial membrane, 
the so-called permeability-transition pores (PTPs) (Gunter et al., 2004); (Pozzan and 
Rizzuto, 2000). Alteration in mitochondrial Ca
2+
 buffering, cause not only disruption 
of normal intracellular Ca
2+
 cycling needed to maintain appropriate Ca
2+
dependent 
signaling pathways and enzyme activities, but also pathological accumulation.  
Mitochondria become overloaded at intracellular Ca
2+
 concentration ([Ca
2+
]i) of 1-
3 µM, inducing membrane depolarization, impaired ATP synthesis, generation of 
reactive oxygen species (ROS), permeability transition and cell death (Gunter et al., 
2004) 
Mitochondria are important normal generators of reactive oxygen species 
(ROS) for cell signaling, but they can also be important contributors to oxidative 
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damage. The toxic effect of ROS is normally counteracted by oxygen defense 
systems consisting of small antioxidant molecules like glutathione, ascorbate, 
coenzyme Q10 and ROS-scavenging enzymes like Mn- and CuZn superoxide 
dismutases, and catalase.  
However, mitochondrial dysfunction and oxidative damage are often claimed to be 
joint contributors to neurodegeneration and it is very likely that oxidative damage and 
ROS production initiates a vicious cycle where ROS mediated damage causes 
mitochondrial dysfunction, which then increases ROS production and so forth, 
resulting in cell damage and activation of cell death pathways generation exceeds 
these protective mechanisms, multiple destructive redox reactions may emerge. 
In the last years several neurodegenerative disorders were associated to one (or more) 
of these mitochondrial dysfunction; it has been published data demonstrating the 
relationship between mitochondrial ATP depletion, Ca
2+
 buffering alteration and 
ROS production for the following neuron diseases: Parkinson’s disease, Amyotrophic 
lateral sclerosis, Alzheimer’s disease, Hungtinton’s disease, Friedreich Ataxia, 
Hereditary spastic paraplegias and SCA28. 
In the following table the mitochondrial proteins involved in human diseases are 
listed. 
Disease  Gene(s) 
mutated 
Mitochondrial 
functions 
Mitochondrial 
alteration 
Parkinson’s disease  Parkin Ubiquitin E3 ligase that 
has been found to be 
ATP depletion 
ROS production 
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associated with the 
outer mitochondrial 
membrane. 
DJ-1 Redox sensor that 
partially localizes to the 
matrix and 
intermembrane space. 
Neuroprotective at the 
mitochondria. 
PINK1 Nuclear-encoded 
mitochondrial kinase. 
Overexpression of 
mutants causes reduced 
mitochondrial 
membrane potential and 
increased death in 
response to inhibitors. 
LRRK2 Kinase associated with 
the outer mitochondrial 
membrane. It has been 
found to interact with 
parkin. 
Amyotrophic lateral 
sclerosis 
SOD I Cytosolic ROS 
scavenging enzyme. It 
partially localizes to the 
intermembrane space 
and matrix. 
ATP depletion 
Ca
2+ 
buffering 
ROS production 
Alzheimer’s disease Amyloid  
β-precursor 
protein 
Its product, β-amyloid, 
is found in the 
mitochondria where it 
binds to amyloid β-
binding alcohol 
dehydrogenase and 
increases ROS 
production. 
ATP depletion 
ROS production 
Presenilins 1 
and 2 
Found at the 
mitochondrial outer 
membrane where they 
are part of the c-
secretase complex that 
cleaves amyloid 
precursor protein. 
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Hungtinton’s 
disaease  
Huntingtin Mutant huntingtin binds 
to the outer membrane 
and reduces 
mitochondrial Ca
2+
 
uptake. It may affect 
mitochondrial 
biogenesis through 
interference with 
nuclear transcription 
factors. 
ATP depletion 
Ca
2+ 
buffering 
 
Friedreich Ataxia Frataxin Mitochondrial protein 
involved in heme 
biosynthesis, formation 
of iron-sulfur clusters 
and iron detoxification. 
ROS production 
Dominant optic 
atrophy 
OPA 1 Inner mitochondrial 
membrane GTPase that 
mediates mitochondrial 
fusion. 
ROS production 
Charcot-Marie-
Tooth type 2A 
Mitofusin 2 Outer mitochondrial 
membrane GTPase that 
mediates mitochondrial 
fusion. 
Ca
2+ 
buffering 
Hereditary Spastic 
Paraplegia 
Paraplegin Subunit of the 
mitochondrial   m-
AAA metalloproteases 
complex. 
ATP depletion 
 
Spinocerebellar 
Ataxia Type 28 
AFG3L2 Subunit of the 
mitochondrial        m-
AAA metalloproteases 
complex. 
ATP depletion 
ROS production 
 
In the last years we have focused our attention to the dissection of the neurological 
and molecular pathological events occurring in Spinocerebellar Ataxia Type 28 
(SCA28).  
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Spinocerebellar ataxia type 28: genetic and molecular features 
 
SCA28 is a form of dominant cerebellar ataxia characterized by unbalanced standing, 
gait incoordination, hyperreflexia of the lower limbs, nystagmus and 
ophthalmoparesis (Cagnoli et al., 2006).  These clinical signs are consequent of a 
cerebellar atrophy caused by Purkinje cells (PCs) degeneration (Fig. B). PCs are 
some of the largest and most complex neurons of the mammalian central nervous 
system. They present extremely branched dendritic trees with a large number of 
active spines, which uniquely receive glutamatergic stimulation of ionotropic α-
Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and 
metabotropic receptors (e.g. mGluR1) as afferent input. PCs are therefore exposed to 
massive and sudden Ca
2+
 influx and are especially vulnerable to glutamate-mediated 
excitotoxicity (Ito, 2002). To control Ca
2+
 homeostasis, PCs take advantage of several 
Ca
2+
 clearance systems: the Ca
2+
 ATP-ase and the Ca
2+-
Na
+
 exchanger at the plasma 
membrane, the Ca
2+
 ATP-ase at the endoplasmic reticulum (ER) and Ca
2+
 binding 
proteins (Gruol et al., 2012). Mitochondria accumulate Ca
2+
 into the matrix, via the 
low affinity mitochondrial Ca
2+
 uniporter (MCU) in a process that depends on the 
electrical potential across the inner membrane (Δψmito) (Pizzo et al., 2012). While 
the capability of mitochondria to internalize Ca
2+
 is undisputed, its functional role in 
living cells, and especially in neurons, is less clear. Compelling evidence indicates 
that mitochondria can act as local Ca
2+ 
buffers in different neuronal types (Colegrove 
et al., 2000) (David and Barrett, 2000) (Montero et al., 2001), but the effective impact 
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of this process on neuronal Ca
2+
 homeostasis and physiology remains to be clarified. 
The efficacy of mitochondrial Ca
2+
 uptake is strictly dependent on the proximity of 
the organelles to the Ca
2+
 source (e.g. ER, plasma membrane, dendritic spines) 
(Duchen, 2012) (Pizzo et al., 2012). Neurons are therefore particularly reliant on 
proper trafficking of mitochondria to these sites and consequently on their dynamic 
properties.  
Several SCA28-causing missense mutations have been identified in the AFG3L2 gene 
(Fig. C) (Cagnoli et al., 2006; Cagnoli et al., 2010; Di Bella et al., 2010; Edener et al., 
2010). AFG3L2 encodes for a mitochondrial protein belonging to the AAA+( ATPase 
Associated to a variety of Activity)-protease superfamily. Moreover, homozygous 
mutations in AFG3L2 are responsible for a myoclonic epilepsy-ataxia-
polyneuropathy syndrome in childhood (Pierson et al., 2011). SCA28 is the first 
autosomal dominant SCA to be caused by alterations in this mitochondrial protein. 
Most of the reported SCA28-causing mutations are heterozygous loss of function 
mutations clustering within the proteolytic domain of AFG3L2. Several pieces of 
evidence support the hypothesis that haploinsufficiency is the SCA28-causing 
mechanism. First, functional studies of human mutant AFG3L2 expression in the m-
AAA-deficient yeast strain indicate that SCA28 mutations alter the proteolytic 
competence of AFG3L2 and result in impaired respiration. However, the 
coexpression of wild type and mutant AFG3L2 is able to correct the respiratory 
defect for most of the mutations, indicating that haploinsufficiency is the disease-
causing mechanism (Di Bella et al., 2010). Remarkably, a partial AFG3L2 deletion 
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(exons 14-16) has been recently identified as the cause of SCA28 in two large 
Belgian families and functional studies revealed a reduced amount of the m-AAA 
complexes in such patients, demonstrating that SCA28 is due to haploinsufficiency 
(Smets et al., 2014).  
Figure B: Cerebellar atrophy in SCA28 patient 
 
Midline sagittal T1-weighted image showing 
cerebellar atrophy, particularly evident in the 
superior vermis. The supratentorial compartment and 
the brainstem are normal. Picture adapted from 
Cagnoli et al., 2006) 
 
 
 
 
 
 
 
 
Figure C: Sca 28-mutations in AFG3L2 
 
Structure of the AFG3L2 gene and composition of the deduced protein. Mutated codons are marked by 
asterisks. MT mitochondrialtargeting sequence; TM1 and TM2 transmembrane domains 1 and 2, 
respectively; FtsH filamentation temperature sensitive H proteolytic domain.  Picture adapted from 
Löbbe et al., 2013 
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Structure and functions of the m-AAA and the i-AAA complexes  
 
AFG3L2 is a mitochondrial inner membrane protein belonging to the AAA-protease 
superfamily (ATPases associated with various cellular activities).  Each AAA 
protease subunit harbors a conserved P-loop ATPase domain of ≈ 230 amino acids, 
which is characteristic of the AAA
+
 superfamily of ATPases (Fig. D) (Hanson and 
Whiteheart, 2005). AAA
+
 proteins convert the energy derived from ATP hydrolysis 
through the action of two specific regions known as Walker A and Walker B which 
perform ATP binding and hydrolysis, respectively. AAA+ proteins convert the 
energy derived from ATP hydrolysis to mechanical work and mediate substrate 
unfolding and remodeling of macromolecular structures, thereby controlling a variety 
of cellular processes. A conserved amino acid stretch present within the AAA 
domain, termed the second region of homology (SRH), defines AAA proteases as 
members of the classical AAA subclass of this superfamily (Iyer et al., 2004). The 
AAA domain of AAA protease subunits is followed by an M41 metallopeptidase 
domain. One or two hydrophobic transmembrane helices within the amino terminal 
region anchor each subunit to the inner membrane. Crystal structures of eubacterial 
FtsH proteases suggest that mitochondrial AAA proteases, like other AAA
+
 proteins, 
represent hexameric, barrel-like assemblies, which are formed by identical or closely 
related subunits and which provide an internal cavity harboring the proteolytic sites 
(Bieniossek et al., 2006; Suno et al., 2006). Two classes of AAA protease complexes 
can be distinguished based on their topology in the inner membrane: i-AAA proteases 
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expose their active sites to the intermembrane side, whereas m-AAA proteases face 
the matrix space (Fig. E) (Tatsuta and Langer, 2009). 
 
 
Figure D-E: AAA proteases in mitochondria.  
 
A) Domain structure and conserved elements in subunits of AAA proteases. Yeast Yta10 is depicted. 
MTS, mitochondrial targeting sequence; ND, N-terminal domain; TM, transmembrane helix; IMS, 
intermembrane space domain; AAA, AAA domain; PD, protease domain; NH, N-terminal helical 
substrate binding region; CH, C-terminal helical substrate binding region; WA and WB, Walker A and 
B motifs of P-loop ATPases; S1 and S2, sensor-1 and 2 motifs; ISS, intersubunit signalling motif; R, 
arginine finger; PL1 and PL2, pore loops 1 and 2. B) Topology and assembly of two distinct AAA 
proteases in the inner membrane of mitochondria. OM, outer membrane; IMS, intermembrane space; 
IM, inner membrane; M, matrix.. Picture adapted from Tatsuta and Langer 2009) 
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First structural information for the eukaryotic AAA
+
 protease was recently obtained 
for the yeast m-AAA protease using single particle electron cryomicroscopy (Lee et 
al., 2011). The m-AAA protease forms a hexamer in solution, resulting in a large, 
ring like molecular machine, with a central pore for substrates to enter into a 
proteolytic chamber. In humans, there are two subunits that comprise the m-AAA 
protease, AFG3L2 and paraplegin. Although both assemble into a heteroligomer, it 
has also been shown that AFG3L2 is capable of assembling into an additional 
homoligomeric complex (Koppen et al., 2007) . The situation is more complicated in 
mouse as there is an additional subunit, AFG3L1, which can also form a 
homoligomeric complex as well as heteroligomeric complexes with AFG3L2 and/ or 
Paraplegin (Koppen et al. 2007).  
The i-AAA protease is composed only of a single subunit, YME1L1. The m-AAA 
and the i-AAA complexes are crucial component of the quality control system in the 
inner membrane, where they mediate the selective degradation of non-assembled and 
damaged proteins (Koppen and Langer, 2007). In addition, they exert chaperone-like 
activity on respiratory chain complexes (Arlt et al., 1998) (Atorino et al., 2003) 
(Maltecca et al., 2008), and regulate the processing of the pro-fusion protein OPA1 
(Duvezin-Caubet et al., 2007) (Ehses et al., 2009) (Ishihara et al., 2006) (Maltecca et 
al., 2012). Moreover, it was demonstrated that the m-AAA is directly involved in the 
maturation of mitochondrial ribosomes subunits MrplL32 maturation (Nolden et al., 
2005), inducing accumulation the precursor in case of absence of the m-AAA. It has 
been demonstrated that MrpL32 doesn’t show a consensus sequence recognized by 
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AFG3L2, but that the m-AAA protease initiates proteolysis from N-terminal amino 
acids of MrpL32 before a folded domain which halts further degradation resulting in 
the release of mature MrpL32 (Fig. F) (Bonn et al., 2011). 
 
Figure F: MrpL32 maturation by the m-AAA complexes 
MrpL32 processing by the m-AAA protease after completion of import allows folding of MrpL32 
within mitochondria. Mature MrpL32 accumulates in a soluble form, if processing occurs by the m-
AAA protease after completion of import, allowing presequence-assisted folding of MrpL32 within 
mitochondria. Image adapted from Tatsuta and Langer 2007 
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Molecular features of Afg3l2 ko and Afg3l2 haploinsufficient mice models  
 
In our lab it has been previously generated the Afg3l2 ko animal model. These mice 
displayed a marked impairment of axonal development with delayed myelination and 
poor axonal radial growth leading to lethality at P16 (Fig. G). It was demonstrated 
that the lack of functional AFG3L2 has deep effects on mitochondrial morphology 
and metabolism. Most mitochondria were morphologically altered in CNS and PNS 
of Afg3l2 ko mice where swollen giant mitochondria with damaged cristae could be 
observed (Fig. H). These aberrant organelles were generally clustered in proximity of 
the nucleus or the plasma membrane. This phenomenon, together with the presence of 
several large vacuoles of mitochondrial origin, was primarily observed in neuronal 
cell bodies of spinal cord anterior horns, in dorsal root ganglia and in PCs, the latter 
indicating a cerebellar involvement. Mitochondrial morphological alterations 
correlated with impaired mitochondrial metabolism in the absence of functional 
AFG3L2. In fact, a dramatic reduction of respiratory complex I and III activities, 
which correspond to stoichiometric limitation of the enzymatic complexes, were 
observed. Insufficient assembling, rather than decreased availability of building 
blocks of respiratory complexes, plays a central role in this deficit of respiratory 
activities, because neither synthesis of mitochondria-encoded subunits nor import of 
nuclear-encoded proteins is impaired. All these data demonstrated a role for AFG3L2 
in effectively assembling complexes I and III (Maltecca et al., 2008).  
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Figure. G: Afg3l2 ko mice model: 
Representative picture of Afg3l2 ko mice model ( on the right) compared to wt littermate. Picture 
adapted from Maltecca et al., 2008 
 
 
 
Figure H: The absence of AFG3L2 induces alteration in the mitochondrial structure. 
 EM analysis of ultrathin sections of cerebellum shows giant mitochondria with swollen, disorganized 
cristae in the mutants (arrows) compared with controls. Picture adapted from Maltecca et al.,  2008. 
  
Introduction  
30 
 
In our lab was also generated and characterized Afg3l2 haploinsufficient mouse, 
which resembles the phenotype of SCA28 patients. 
Afg3l2 heterozygous mice develop normally and show normal appearance and 
fertility. Afg3l2 heterozygous mice showed alterations in gait coordination, balance, 
pelvic elevation, and negative-geotaxis reflex; all symptoms correlated to cerebellar 
dysfunction.  These defects appear at 4 months and worsen with age, and mutants 
older than 12 months present abnormal gait characterized by uncoordinated hind limb 
movement. These findings demonstrate that the Afg3l2 haploinsufficient model 
recapitulates features of SCA28 patients, such as unbalance standing and slowly 
progressive gait incoordination (Cagnoli et al., 2006). 
Maltecca and colleagues (Maltecca et al., 2009) demonstrated that progressive 
decline in motor performances is caused by PC-DCD. The latter is a specific form of 
cell degeneration intermediate between necrosis and apoptosis and is characterized by 
cell shrinkage, cytoplasm darkening and chromatin condensation (Leist and Jaattela, 
2001). In the SCA28 mouse this phenomenon is unique since it originates from 
mitochondrial dysfunction (Maltecca et al., 2009), while in other forms of SCA is 
associated to excitotoxicity and high levels of intracellular Ca
2+ 
(Custer et al., 2006) 
Ikeda (Ikeda et al., 2006) (Kasumu and Bezprozvanny, 2012). The appearance of 
morphologically altered mitochondria precedes DCD; swollen mitochondria with 
damaged cristae were detected already at 4 months, contemporary to the onset of 
motor coordination defects, while PC-DCD were detected at 6 months (Fig. I). 
Moreover, it has been detected marked reduction of ATP synthesis associated with a 
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reduced activity of respiratory complexes I and III. Consistent with what observed in 
Afg3l2 homozygous mutants, faulty assembly caused by reduced AFG3L2 chaperone-
like activity rather than decreased availability of complex subunits is at the basis of 
this deficit in respiratory activities. Inhibition of complexes I and III is known to 
diminish ATP production, to increase leakage of electrons and production of ROS, 
which attack intracellular biomolecules (Murphy, 2009). Proteins are one of the major 
targets of oxygen-free radicals and other reactive species. In line with this scenario, in 
Afg3l2 haploinsufficient mutants it was reported strikingly increased levels of protein 
carbonyls in cerebellar mitochondrial enrichments as well as in total lysates. 
Carbonylation has irreversible and unrepairable consequences modulating 
biochemical characteristics of proteins such as enzymatic activity susceptibility to 
proteolytic degradation (Nystrom, 2005). This evidence indicated that dysfunction of 
the respiratory chain caused by the lack of AFG3L2 cannot be counterbalanced by the 
mitochondrial antioxidant system, leading to increased reactive oxygen species 
(ROS) production and oxidative damage (Maltecca et al., 2009). 
Nevertheless, what is the molecular link between the mitochondrial alteration and the 
PCP-DCD is not clarified.  
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Figure I: Aberrant mitochondria in PCs:   
Ultrathin sections of cerebellum from Afg3l2 heterozygous and syngenic control mice at 4, 6, and 12 
months are shown .a– h, Mutant PCs show aberrant mitochondria (arrowheads) in the cellular bodies 
and also in the dendritic synapses. Image adapted from Maltecca et al., 2009 
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Neurodegeneration and mitochondrial dynamics 
Many neurodiseases are associated with changes in mitochondrial function and 
morphology. Neurons have an especially high demand for mitochondrial metabolism 
and are particularly sensitive to decreases in mitochondrial function, which lead to 
energy deprivation and ROS production. By controlling organelle size, mitochondrial 
fission and fusion also facilitate the efficient microtubule- mediated active transport 
of mitochondria into the long dendritic and axonal extensions characteristic of highly 
polarized neurons. As said before, alteration in mitochondrial dynamics, cause by 
inhibition on mitochondrial fission or fusion, have been suggested to occur as early 
events during the pathogenesis of many diseases.  It was reported that an increase in 
fission event is reported for AD, PD and HD; while the alteration of fusion event can 
induce CMT II A or ADOA.  
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Mitochondrial dynamics. 
 
The antagonistic activities of mitochondrial fission and fusion are required to 
maintain the form and function of mitochondria. Mitochondrial fusion facilitates 
communication and sharing of contents between mitochondrial compartments, which 
can buffer transient  defects in mitochondrial function (Chen and Chan, 2010). 
Mitochondrial division facilitates the transport, distribution, and quality control-
mediated degradation of the organelle (Fig. L) (Lackner and Nunnari, 2009).  The 
dynamic processes of mitochondrial division and fusion are mediated by dynamin 
related proteins  (DRPs). DRPs are a family of large GTPases that harness  GTP-
dependent self-assembly and subsequent GTP  hydrolysis-mediated conformational 
changes to remodel  membranes (Faelber et al., 2013; Praefcke and McMahon, 2004). 
The DRP Dnm1/Drp1 (yeast/mammals)  drives the scission of mitochondrial 
membranes and the DRPs Fzo1/Mfn1/2 and Mgm1/Opa1 mediate  fusion of the 
mitochondrial outer and inner membranes  (MOM and MIM), respectively (Hoppins 
et al., 2007). 
 
Figure. L: mitochondrial fusion and fission balance  
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Mitochondrial fission   
 
The dynamin related GTPase Dnm1/Drp1 is a core component of the mitochondrial 
division machine (Smirnova et al., 2001). Dnm1/Drp1 assembles into helical 
structures that wrap around mitochondria and mediate the scission of mitochondrial 
membranes (Smirnova et al., 2001). GTP binding  drives Dnm1/Drp1 helix assembly, 
which in turn triggers GTP hydrolysis via the formation of a catalytic interface 
between the GTPase domains of molecules in adjacent helical rungs (Frohlich et al., 
2013) (Ingerman et al., 2005). Consequent GTP hydrolysis-driven conformational 
changes in the helix result in further constriction and ultimate scission of the 
underlying mitochondrial membranes (Mears et al., 2011). Drp1-mediated membrane 
remodeling is subject to regulation at various points in the division pathway, 
including targeting of Drp1 to the mitochondrial outer membrane (MOM) and 
modulation  of the GTP-regulated assembly, constriction, and disassembly of the 
Drp1 helix. Post-translational modification (PTM) of Drp1, which includes 
phosphorylation, sumoylation, ubiquitination, nitrosylation and O-glycosylation,  can 
positively or negatively impact Drp1 activity, and alternative RNA splicing produces 
functionally  distinct Drp1 isoforms, which themselves are subject  to differential 
PTM (Strack et al., 2013). The activity of the mitochondrial division DRP is also 
regulated by protein effectors (adaptors): Mdv1 in yeast and Fis1, Mff, MiD49 and 
MiD51 in mammals (Zhao et al., 2011). These effectors function to target and/or 
regulate the assembly of the division DRP on the mitochondrial surface, providing 
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critical spatial and temporal regulation (Koirala et al., 2013). Distinct combinations of 
Drp1 isoforms, effectors and PTMs provide contextual regulation to Drp1 activity 
and allow for the integration of mitochondrial division with cellular needs. For 
example, site-specific phosphorylation activates Drp1 activity during mitosis, which 
facilitates segregation of mitochondria into daughter cells (Taguchi et al., 2007). 
During nutrient starvation, the phosphorylation of one site  and dephosphorylation of 
another attenuate Drp1 activity,  leading to mitochondrial elongation, which protects  
mitochondria from autophagic degradation and sustains cell viability (Gomes et al., 
2012). Recent studies indicates that mitochondrial division site selection involves 
communication  between unexpected extramitochondrial factors  and internal 
mitochondrial structures. The initial observation that the ER physically wraps around 
mitochondria and facilitates mitochondrial constriction at nascent division sites added 
a novel player to the mitochondrial division pathway (Friedman et al., 2011). ER-
mediated mitochondrial constriction occurs upstream of Drp1 recruitment and 
represents an early stage in mitochondrial division (Friedman et al., 2011). In 
mammalian cells, an ER-associated form, INF2, has been functionally linked to this 
early stage mitochondrial constriction (Korobova et al., 2013). Evidence indicates 
that INF2 mediates actin polymerization and subsequent myosin recruitment to sites 
of ER-mitochondria contact, providing a force-generating mechanism to drive the 
constriction of mitochondria (Korobova et al., 2014). This initial constriction likely 
generates a geometric hotspot that is more favorable for Drp1 helix assembly 
(Friedman et al., 2011). Finally, based on the recent addition of novel and unexpected 
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players to the mitochondrial division pathway in both yeast and humans, it is clear 
that our knowledge of the entire complement of proteins that comprise and regulate 
the division complex is far from complete (Fig. M) 
. 
Figure M: Mitochondrial fission DRP1 mediated: 
Dynamin-related protein-1 (DRP1) is normally phosphorylated and sequestered in the cytoplasm. At 
the endoplasmic reticulum (ER)–mitochondria contact site where ER tubules cross over and wrap 
around mitochondria in presence of F-actin and its ER receptor INF2, dephosphorylated dynamin-
related protein 1 (DRP1) is recruited to the OMM where it oligomerizes and interacts with its receptors 
and mediates mitochondrial constriction. Image adapted from Kasahara et al., 2014 (Kasahara and 
Scorrano, 2014) 
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Mitochondrial fusion   
 
Fusion of mitochondrial outer membranes is mediated by a different set of Dynamin 
family members. The first of these was discovered in Drosophila sperm cells, where it 
was named fuzzy onions for the onion-like and fuzzy appearance of unfused 
mitochondria in electron micrographs of these mutants (Hales and Fuller, 1997). A 
second mitochondrial outer membrane protein, named Marf, was later shown to 
mediate fusion in other cell types (Dorn et al., 2011). The sequences of Marf and 
fuzzy onions are similar, but their expression patterns are different so the mutants 
have different phenotypes: fuzzy onions mutants are sterile whereas Marf mutants are 
lethal (Dorn et al. 2011). Yeast and Caenorhabditis elegans each have only one fuzzy 
onions or Marf homolog (Fzo1p and FZO-1, respectively) (Hermann et al., 1998; 
Rapaport et al., 1998). Mammals do have two homologs (the Mitofusins Mfn1 and 
Mfn2), but those are often expressed in the same cells (Chen et al., 2003; Santel and 
Fuller, 2001). Although some functional differences between Mfn1 and Mfn2 have 
been observed, both of these proteins are also able to support mitochondrial fusion by 
themselves, suggesting that they fulfill partially redundant functions in this process 
(Chen et al. 2003). Mitochondrial outer membrane fusion is almost always 
coordinated with inner membrane fusion (Fig. N). There are, however, some 
instances in which outer membrane fusion can occur without concomitant inner 
membrane fusion as, for example, when mutations or loss of membrane potential 
block inner membrane fusion whereas outer membrane fusion can still occur (Olichon 
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et al., 2003). Localized loss of membrane potential and its effects on inner membrane 
fusion may explain why the matrix compartments in larger mitochondrial networks 
sometimes have breaks, whereas their outer membranes appear to be fully fused. The 
physiological relevance of these observations has not yet been explored. In 
comparison to the division DRPs, less is known about the mechanism by which 
fusion DRPs harness GTP driven self-assembly and GTP hydrolysis-mediated 
conformational changes to fuse membranes. Current evidence indicates that MOM 
and MIM fusion proceed via two separable stages, membrane tethering and lipid 
content mixing, both of which require fusion DRPs (Song et al., 2009). Membrane 
tethering is mediated by fusion DRP1 self-assembly, and subsequent GTP hydrolysis-
induced conformational changes are proposed to destabilize the lipid bilayers of the 
tethered fusion partners to facilitate lipid mixing and fusion. While assembled 
structures of the fusion DRPs have been observed by electron microscopy,  it is not 
yet clear if and how these structures correlate to  active fusion complexes (Abutbul-
Ionita et al., 2012). Like the mitochondrial division DRP, the mitochondrial  fusion 
DRPs are subject to various levels of regulation, including  alternative splicing, PTM, 
proteolytic processing  and regulated protein degradation, all of which can link  
mitochondrial fusion with cellular physiology. For example, one of the peptidases 
responsible for Opa1 processing, OMA1, has been shown to be activated in response 
to various cellular stressors (Baker et al., 2014). Under such conditions, enhanced 
Opa1 processing correlates with attenuated fusion and stress-induced mitochondrial 
fragmentation. In contrast, OXPHOS-stimulated processing of Opa1 via the peptidase 
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Yme1L has been shown to stimulate MIM fusion (Mishra et al., 2014). Recent work 
demonstrates that acetylation can also regulate Opa1 activity. Acetylation of OPA1 
reduces its activity, and the acetylated state; thus, function of OPA1 can be modulated 
by the mitochondrial deacetylase Sirt3 (Samant et al., 2014). As the sirtuin is 
dependent on NAD+, its activity is highly sensitive to the metabolic state of the cell. 
Thus, context-specific processing and PTM of Opa1 link MIM fusion to both cellular 
health and metabolism. Acetylation is also proposed to regulate MOM fusion under 
certain stress conditions by promoting the ubiquitination and subsequent degradation 
of Mfn1 (Park et al., 2014). Phosphorylation and ubiquitination can also trigger 
Mfn1/2 degradation and   thus inhibit MOM fusion in response to specific stimuli 
(Leboucher et al., 2012). In addition to promoting degradation, site-specific   
ubiquitination can stabilize MOM fusion DRPs, as it has been shown for Fzo1, and 
promote fusion, perhaps via the   stabilization of Fzo1 oligomers (Anton et al., 2013). 
Regulation of the oligomeric   state of Mfn2 via modification by oxidized glutathione 
has also been proposed to promote mitochondrial fusion (Shutt et al., 2012). 
Additionally, localization of Mfn2 to both the MOM and ER raises the possibility that 
differential targeting of the protein can also be used as a means to regulate fusion. As 
interactions between ER-associated Mfn2 and mitochondrial-associated Mfn1/2 
function to tether the two organelles (De Brito and Scorrano, 2008), ER-
mitochondrial contacts may also play direct and/or regulatory roles in mitochondrial 
fusion  
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. 
Figure N: mitochondrial outer and inner membrane fusion: 
Mfn1 and 2 mediate outer mitochondrial membrane (OMM) tethering through the interaction of 
adjacent C-terminal regions, which leads to subsequent OMM fusion by GTP hydrolysis through Mfn. 
OPA1 is required in IMM fusion and the maintenance of cristae structure. Picture adapted from (Zhan 
et al., 2013) 
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Dynamin-like 120 kD protein, mitochondrial (OPA1)  
 
In the last years compelling evidence points at the1 Dynamin-like Optic Atrophy 1 
GTPase (OPA1) processing a pivotal step in fusion and fission events.  OPA1 exists 
in different splicing isoforms that can be partially or totally proteolytically processed 
at one or two distinct sites according to the nature of the isoform. Nevertheless, a 
general OPA1 domain organization can be recognized. OPA1 mitochondrial 
localization is assured by a bipartite-type mitochondria targeting sequence (MTS) 
present in the 5' end of the coding region. Downstream this sequence there is the 
cleavage signal for the mitochondria processing peptidase (MPP) that cleaves off the 
MTS upon OPA1 import into mitochondria. Mature OPA1 lacks the MTS and 
includes in its N-terminal portion hydrophobic regions, the more hydrophobic 
predicted to constitute a membrane-spanning domain that anchors OPA1 to the IMM 
and projects the bulk of the protein towards the IMS, leaving the N-terminal tail 
protruding in the matrix space (Ishihara et al., 2006). Downstream this tract, there are 
the GTPase domain, a middle domain and the GTPase effector domain (GED) 
(Hoppins et al., 2007). In the first third and in the C-terminal portion of OPA1 there 
are also regions that assume a coiled-coil conformation that is important for OPA1 
self-association (Akepati et al., 2008). In fact, OPA1 can oligomerise forming in 
mouse 184 kDa dieters and 258 kDa complexes (Akepati et al., 2008). Alternative 
splicing interests OPA1 N-terminal portion; in particular, in human, exons 4, 4b, and 
5b can be present or not in the mature mRNA. All the combinations in which these 
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exons can arrange give rise to eight different OPA1 isoforms (Song et al., 2007). In 
mouse, there are only four alternative splicing products since exon 4 is not 
alternatively spliced (Akepati et al., 2008). Moreover, OPAI can undergo proteolytic 
cleavage at two sites, S1 and S2. S1 is located in exon 5 and is present in all OPA1 L 
isoforms; on the contrary, S2 is contained in exon 5b and therefore is present only in 
isoforms 4, 6, 7, and 8 in human and only in isoforms 7 and 8 in mouse. (Fig. O). 
(Akepati et al., 2008; Song et al., 2007)  
 
Figure O: OPA1 isoforms 
OPA1 isoforms alternative splicing in human and mouse. Cleavage sites are depicted. Picture adapted 
from Song et al., 2007 
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The combination of splicing isolorms and proteolytic cleavage results in Western blot 
analyses in five distinct bands, named from L1-L2-S1-S2-S3. The distribution of 
OPA1 cleaved and un-cleaved forms in human and mouse is depicted in Fig.P . The 
assignment of the content of each OPA1 band is based on the work of Song et al., 
2007, in which authors expressed single or combinations of tagged OPA1 variants in 
OPA1- null cells.  
 
     P 
 
 
Figure P: OPA1 western Blot and cleavage form distribution 
  
 OPA1 isoform 
 Human Mouse 
L1 7 7 
L2 1-2-4 1 
S1 4-6-7-8 7-8 
S2 4-6-7-8 7-8 
S3 1-2-3-5 1-5 
Introduction  
45 
 
OPA1 Processing  
 
The proteolytic processing of OPA1 is a fundamental step in mitochondrial dynamics 
and a recent work explained in which way this cleavage can induce fusion or fission 
(Anand et al., 2014). Non-processed forms of Opa1 (long Opa1) are sufficient to 
mediate mitochondrial fusion, while the accumulation of processed forms (short 
Opa1) correlate with mitochondrial fragmentation without negatively effecting fusion 
rates, indicative of a  role for short Opa1 in division. Cleavage of OPA1 and its yeast 
homolog Mgm1 as well as the assembly of long and short isoforms is stimulated by 
cardiolipin, resulting in the stimulation of the GTPase activity, which promotes 
mitochondrial fusion (DeVay et al., 2009). It is presently not understood how a 
balanced formation of long and short isoforms of OPA1 is ensured. The IM rhomboid 
protease, Pcp1, is responsible for cleavage of Mgm1 in yeast (McQuibban et al., 
2003); (Sesaki et al., 2003); (Herlan et al., 2004).The mammalian homolog of Pcp1, 
PARL, has been linked to the release of short OPA1 isoforms from mitochondria 
during apoptosis and suggested to play a role in OPA1 processing (Cipolat et al., 
2006). However, studies in cell lines lacking PARL revealed that it is dispensable for 
OPA1 cleavage (Cipolat et al., 2006); (Duvezin-Caubet et al., 2007) (Ehses et al., 
2009). Rather, the i-AAA protease Yme1 has been implicated in generation of at least 
one short form of OPA1 by constitutive cleavage at the processing site S2 (Song et 
al., 2007). Loss of Yme1 results in loss of a particular short isoform of OPA1 and is 
accompanied by a highly fragmented mitochondrial morphology (Griparic et al., 
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2007) (Song et al., 2007). Components of the m-AAA protease have also been shown 
to influence OPA1 processing. In a heterologous system, subunits of the mammalian 
m-AAA protease were able to cleave OPA1 when coexpressed in yeast (Duvezin-
Caubet et al., 2007). Loss of the m-AAA protease in mammalian cells results in 
enhanced processing of the long OPA1 isoforms, accompanied by fragmentation of 
the mitochondrial network and loss of cristae structures (Ehses et al., 2009). Stress-
induced degradation of long OPA1 isoforms was found to be mediated by OMA1 
(Ehses et al., 2009) (Head et al., 2009). The increased cleavage of OPA1 by OMA1 
occurs rapidly in response to different mitochondrial insults, ensuring that a damaged 
mitochondrion can be efficiently segregated from the network and removed through 
mitophagy in a rapid fashion (Fig. Q)  
Figure Q: OPA1 processing and mitochondrial dynamics 
.   
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The stress activated OMA1 protein  
 
In the last years our lab has focused its attention on the role of  OMA1 in 
mitochondrial dynamics, a new member of a conserved and widespread family of 
membrane-bound M48 metallopeptidases. Oma1 was identified in yeast 
mitochondrial inner membrane as a peptidase that can substitute for the function of 
the m-AAA pro-tease during degradation of a misfolded membrane protein (Kaser et 
al., 2003). Similarly, synthetic growth defects have been observed when mutations in 
the bacterial AAA protease FtsH were combined with mutations in HtpX, which is a 
distant homologue of OMA1, indicating overlapping proteolytic activities (Shimohata 
et al., 2002). It was demonstrated that OMA1 can cleave OPA1 in S1 site (Ehses et 
al., 2009; Head et al., 2009). The substrate specificity of OMA1 is distinct from yeast 
Oma1, which cleaves neither OPA1 when expressed in yeast nor the yeast OPA1 
homologue Mgm1 (Duvezin-Caubet et al., 2007). It was demonstrated that OMA1 
promotes OPA1 processing if mitochondrial activities are impaired. The loss of 
mtDNA, dissipation of Δψm, decrease of mitochondrial ATP levels, heat shock, ROS 
production induces OPA1 processing by OMA1 (Baker et al., 2014); Ehses et al., 
2009; Head et al., 2009). The characterization of the OMA1 null mice model 
demonstrated that OMA1 performs OPA1 processing even in physiological 
condition; in fact, Oma1 ko MEFs lack OPA1 form S1 and form S3 clearly indicate 
that OMA1 is responsible for the in vivo proteolytic processing of L-OPA1 forms 
(Quiros et al., 2012). Notably, even under stress conditions, Oma1 ko cells display 
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the same pattern of OPA1 isoforms characterized by the lack of processing of L-
OPA1, which finally results in the shift of mitochondrial dynamics towards fusion 
events.   
Interestingly OMA1 null mice model doesn't show significant neurological alterations 
in adult mice differently from what observed in the absence of paraplegin or 
AFG3L2, other two regulators of same mitochondrial pathway. Nevertheless 
deficiency in OMA1 induces the obesity phenotype, which leads us to suppose a new 
and unexpected role for this mitochondrial protease in metabolic control. Quirós and 
colleagues demonstrate that Oma1 deficiency causes reduced energy expenditure, 
which agrees with previous results, indicating that a reduction in energy expenditure 
causes obesity in animal models (Lowell et al., 1993); (Feldmann et al., 2009). 
Accordingly, the reduced energy expenditure in Oma1-deficient mice may account 
for their increased adipose mass. In addition, Oma1 deficiency causes a reduced 
expression of nuclear genes encoding for mitochondrial proteins and key metabolic 
transcription co-activators, so this may be instrumental in the reduced energy 
expenditure shown in Oma1-null mice. Moreover, deregulation in lipid metabolism 
due to defects in β-oxidation genes observed in Oma1-deficient mice contributes to 
the obesity and thermoregulation defects.   
The authors speculated that altered OPA1 processing induces changes in 
mitochondrial dynamics, modifying expression levels of dynamic proteins to 
compensate or counteract this deficiency. Thus, under physiological conditions and in 
the absence of any relevant stressor, the lack of OMA1 induces changes in 
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mitochondrial dynamics without seriously affecting any physiological function. In 
this situation, Oma1-deficient mice display a modest increase in body weight, 
improvement in glucose metabolism, hepatic steatosis, decrement in energy 
expenditure and low body temperature. However, under stress conditions such as a 
high-fat diet, the lack of OMA1 induces obesity, loss of glucose metabolism 
improvement and decrease in β-oxidation that induce the marked increase in the 
expression of genes of the lipogenic pathway and manifests as the significant hepatic 
steatosis observed in Oma1-deficient mice. Finally, and in relation to the putative 
implications of these findings for human metabolic control, several genome-wide 
linkage studies have found evidence of a quantitative trait locus for human obesity 
phenotypes in the region harbouring OMA1 (Choquette et al., 2008); (Saar et al., 
2003).   
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OMA1 structure and activation 
 
OMA1 predicted molecular weight is 60 kD but recent data support the idea that the 
cleaved OMA1 40 kD form performs OPA1 processing, which is in turn processed by 
an auto-catalytic mechanism that involves the C-term part of the protein generating a 
smaller form (Baker et al., 2014).  OMA1 40 kD form oligomerises into a complex of 
200–300 kD and it was proposed that its proteolytic activity is regulated by 
intermolecular interactions of C-terminal helices within the oligomer (Baker et al., 
2014). It is known that the 60 kD form is imported inside the mitochondria where it 
will be processed and that stress condition induces the 60 kD form accumulation. 
Head and colleagues demonstrated by carbonate extraction, that OMA1 full length is 
an integral membrane protein and not only an associated mitochondrial outer 
membrane protein (Head et al., 2009). Nevertheless, nothing is known about the 
generation of OMA1 40 kD band and which is/are the protease(s) involved in this 
mechanism.  
OMA1 is constitutively active on OPA1 but it was demonstrated that there is an 
overactivation during cellular stress conditions (i.e. ATP depletion, ROS production, 
Δφ depletion). Activation of OMA1 critically depends on positively charged amino 
acids within the N-terminal domain of OMA1 and is accompanied by its autocatalytic 
degradation, which is initiated from C-terminal ends and results in the complete 
turnover of OMA1. It was demonstrated that OMA1 activity under stress critically 
depends on an N-terminal domain outside the conserved M48 metallopeptidase 
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domain, which is composed of a hydrophobic region and a cluster of positively 
charged amino acids. While the proteolysis by OMA1 depends on hydrophobic amino 
acids within this domain, the following cluster of positively charged amino acids was 
found to be critical for OMA1 activation in depolarized mitochondria. Authors 
proposed that this domain is a sensor domain, perhaps stabilized by ionic interactions 
with negatively charged phospholipid head groups, which induces conformational 
changes in OMA1 upon membrane depolarization leading to its activation and 
autocatalytic turnover (Fig. R-S)  (Baker et al.,2014). Clearly, structural information 
on OMA1 is required to substantiate this hypothesis. It is noteworthy, however, that 
the structural characterization of distantly related metallopeptidases from 
thermophilic prokaryotes suggests novel intra- and intermolecular latency 
mechanisms (Lopez-Pelegrin et al., 2013). These include intermolecular interactions 
of C-terminal helices within an oligomer that impair proteolytic activity. Such a 
scenario may explain the accelerated processing of OPA1 upon deletion of C-terminal 
amino acid residues in OMA1. This regulatory mechanism ensures the reversibility of 
the response and allows restoration of the mitochondrial network upon alleviation of 
stress stimuli or repair of mitochondrial damage.  
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Figure Q and R: OMA1 structure 
Picture adapted from Baker et al., 2014 
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AIM OF THE WORK 
 
SCA 28 is a form of autosomal dominant cerebellar ataxia, characterized by gait 
difficulties, nystagmus, ophtalmoparesis and hyperreflexia. Many SCA28-causing 
mutations were discovered in the last years in the AFG3L2 gene. This gene codifies 
for a mitochondrial protease of the inner membrane belonging to the AAA-protein 
family that can assemble into homo-oligomers and hetero-oligomers with paraplegin 
forming the m-AAA complex. The role of this complex is not totally clarified but 
different evidence shows that it is involved in protein quality control of the inner 
membrane and mediates chaperone-like activity on respiratory chain complexes. 
Moreover, it controls mitochondrial morphology by regulating the processing of the 
pro-fusion protein OPA1. The Afg3l2 haploinsufficient mouse recapitulates most 
features of SCA28 patients. It displays defects in motor coordination and balance due 
to PCs degeneration. Mutant PCs show increased electron density and condensed 
cytoplasm and nucleus but no signs of nuclear blebbing or apoptotic bodies. These 
features are peculiar of dark cell degeneration (DCD) that is characteristic of 
excitotoxic injury. Intriguingly, in the SCA28 model this type of degeneration 
originates for the first time from mitochondrial dysfunction. Indeed, histological 
studies on Afg3l2 heterozygous cerebellum show dramatic defects in mitochondrial 
morphology and cristae organization, in fact biochemical investigations revealed 
reduced activity of the respiratory chain. Mitochondrial phenotypes precede PC-
DCD, demonstrating the mitochondrial origin of the degeneration. 
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We hypothesized that the pathological mechanism at the basis of PC-DCD in SCA28 
mice involves defective Ca
2+ 
internalization in mitochondria as a triggering event. 
This can in turn cause alteration of Ca
2+ 
homeostasis and pathological accumulation 
of Ca
2+ 
in Afg3l2 heterozygous PCs in condition of normal glutamate stimulation, 
thus mimicking exitotoxic-mediated DCD. Indeed, it is well known that 
mitochondrial Ca
2+
 buffering has a key role in the regulation of cellular Ca
2+
 
homeostasis, especially in neurons. 
The project is aimed at dissecting the molecular pathogenesis of SCA28 at the 
mitochondrial level and at clarifying the missing molecular link between loss of 
AFG3L2 and mitochondrial dysfunction. 
One direction of the research was focused on the link between loss/haploinsufficiency 
of Afg3l2, altered mitochondrial metabolism and DCD. Considering that DCD is 
characterized by excitotoxic injury, we wanted to verify if the absence of AFG3L2 
induces an alteration in the mitochondrial Ca
2+
 buffering and if the hypothetical Ca
2+
 
deregulation could be linked to altered mitochondrial morphology. 
The second part of my research work was centered on the mitochondrial 
morphological defects due to the absence of AFG3L2. In particular, I focused on the 
link between AFG3L2 and mitochondrial dynamics studying the regulatory 
mechanism the pro-fusion protein OPA1 and its regulator OMA1.
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MATERIAL AND METHODS  
Chemicals and suppliers 
Chemicals 
All chemicals were obtained from Sigma-Aldrich, if not otherwise indicated. Cell 
culture media and reagents purchased from GIBCO Cell Culture Systems 
(Invitrogen). 
 
Antibodies  
Anti-HA antibody was from Sigma-Aldrich (St. Louis, MO, USA) Anti-OPA1 
antibody was from BD Transduction Laboratories (Franklin Lakes, NJ, USA), anti-
Hsp60 and Hsp70 antibodies were from Stressgen (San Diego, CA, USA), anti-
GAPDH was from Santa Cruz Biotechnology,INC. (Europe), anti-c-Myc antibody 
was from Novus biologicals ( Cambrige, UK), anti-YME1L1 antibody was from 
ProteinTech Group (Chicago, USA) anti-AFG3L2 and anti paraplegin were 
previously generated in our lab(Atorino et al., 2003), anti beta –tublin was from 
DSHB ( university of Colorado, Colorado;USA); anti beta-actina was from Sigma 
Aldrich(St. Louis, MO, USA), TIM44 and TIM23 were from BD transduction 
laboratories ( Qume DriveSan Jose, CA,USA), anti –porin was from Calbiochem 
(EMD biosciences, INc. la Jolla, CA,USA), anti MFN2 was from Abcam 
(Cambridge, UK). 
ECL anti mouse and anti rabbit IgG, horseradish peroxidase (HRP)-linked species 
specific whole antibodyes were purchased from Amersham Biosciences (UK). 
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Polycolonal rabbit anti-goaqt immunoglobulins/HRP were obtained from 
DakoCytomation ( Denmark) 
 
DNA oligonucleotides 
DNA oligonucleotides were purchased from Primm srl (Milan, Italy).  
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Cell line cultures 
Mouse embryonic fibroblast (MEFs) 
All cell lines were cultured at 37°C in 95% humidified air and 5% CO2 
Primary MEFs were established from embryonic day E16.5 from Afg3l2 knockout, 
heterozygous and wild type embryos (Maltecca et al., 2008) and immortalized by 
SV40 (Schuermann, 1990), using 300 g/ml geneticin for selection. MEFS were 
cultured in D-MEM medium supplemented with 5% FBS, 2 mM L-glutamine and 
Sodium Pyruvate 1 mM. 
Human cell lines 
HeLa cells were maintained in Dulbecco’s Modified Eagle’s Medium containing 
penicillin/streptomycin, 10% fetal bovine serum, 1 mM L-glutamine and Sodium 
Pyruvate 1M.  
Human immortalize fibroblasts from a control and the patiens belonging to SPG7 
family (De Michele et al., 1998) were obtained from Istituto Neurologico Besta 
(Milan, Italy). Cells were cultured in D-MEM medium supplemented with 10% FBS, 
2 mM L-glutamine and Sodium Pyruvate 1 mM.  
Primary Purkinje cells  
For primary PC cultures, a modified version of previously described protocols 
(Tabata et al., 2000) was used. Cerebella from newborn mice were incubated in 
Hanks’ balanced salt solution 1X (HBSS, Gibco, Paisley, UK) containing 5 U/mL 
papain (Sigma), 50 mg/mL cystein-HCl, 0.1 mM EDTA and 1 mg/mL DNase I 
(Millipore) for 30 min at 37°C. Tissues were then dissociated by mechanical 
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trituration. The reaction was blocked with 10% horse serum and samples were 
centrifuged at 1200 rpm for 10 min. The cellular pellet was washed twice in HBSS 
1X and resuspended in a cultured medium containing: Neurobasal (Gibco), B27 
supplement (Invitrogen), 200 mg/mL D-glucose, 2 mM GlutaMax (Gibco), 100 
U/mL PenStrep (Gibco), 1% horse serum (Invitrogen), 3 mM KCl, 50 ng/mL 2.5 S 
NGF (Millipore). Cells were plated at a density of 1.5 x 10
4
/cm
2
 on coverslips (14 
mm or 24 mm in diameter) or bottomglasses (Mattek, Ashland, MA, USA) coated 
with Poly-L-lysine (Sigma). 
  
Material and Methods  
59 
 
Imaging 
Imaging analysis on MEFs cells  
Analysis of mitochondrial network morphology was performed as described (Cipolat 
et al., 2004) by expressing a mitochondrial targeted enhanced yellow fluorescent 
protein (mtYFP, Clontech, Mountain View, CA, USA) and live imaging confocal 
microscopy. An average of 150 cells were analyzed for each experimental condition. 
Cells were divided into three classes accordingly to mitochondria shape: tubular 
mitochondrial network, intermediate or fragmented mitochondrial structures. 
Experiments were repeated at least three times, and three operators analysed the 
images, independently. Chi squared test on row data was applied for significance 
calculation (degrees of freedom=2).  
For the analysis of mitochondrial and ER volumes, cells were transfected with 
mitochondrial targeted red fluorescent protein mt-RFP (Clontech, Mountain View, 
CA, USA) and ER- targeted green fluorescent protein (ER-GFP, kindly provided by 
R. Sitia) and stacks of consecutive confocal images taken at 0.1-μm intervals were 
acquired. 3D reconstruction and volume rendering were performed using Volocity 3D 
Image Analysis Software vers. 5.5.1, Perkin Elmer, Norwalk, MA, USA.   
Manders’ coefficient was applied for the quantitative analysis of mitochondria-ER 
colocalization. In all the experiments, confocal microscopy was performed using 
Perkin Elmer UltraVIEW Spinning Disk Confocal Microscope and EMCCD 
Hamamatsu C9100 imaging camera. The system is equipped with a stage incubator 
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from OkoLab (www.okolab.com), allowing to work with live cells maintained under 
stable conditions of temperature, CO2 and humidity.  
For each cell, the total number of objects mitochondria was identified using the IN 
Cell Developer Toolbox 1.8 (GE Healthcare, Little Chalfont, UK). After the 
optimisation of segmentation parameters, a mask was created to cover the 
mitochondrial network. This mask was projected on the ER. At this point a threshold 
was set in order to classify mitochondria using the green (ER) intensity. Mitochondria 
with a green  signal intensity greater than or equal to the threshold were classified as 
in contact with the ER, whereas mitochondria with a green signal intensity less than  
threshold were classified as free of contacts.  
 Morphometric analyses of primary PCs 
IF were performed on primary PCs at 14 DIV. Stacks of consecutive confocal images 
were taken at 0.3 μm intervals using Perkin Elmer UltraVIEW Spinning Disk 
Confocal Microscope (Norwalk, MA, USA). The analyses of soma/dendrites area and 
total mitochondria volume were performed using Volocity 3D Image Analysis 
Software version 5.5.1 (Perkin Elmer). For the mitochondrial volume evaluation, a 
ROI was drawn to cover the profile of each PC (or dendrites only). A threshold for 
the red signal (mitochondria) and green signal (PCs) was set in order to exclude 
background. Mitochondria with red signal intensity greater than or equal to the green 
threshold were identified as belonging to PC. This analysis was extended to the whole 
cell volume.  
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 Electron microscopy 
The semithin and ultrathin sections from mouse tissues and on primary PCs at 14 
DIV were prepared as previously described (Maltecca et al., 2009).  
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Ca
2+
measurement 
Ca
2+
measurement in MEFs cells 
MEFs grown on 13 mM round glass cover slips at 50% confluence were transfected 
with the cytosolic (cytAEQ) or mitochondrial aequorin probes (mtAEQmut or 
mtAEQ). Cells were reconstituted with 5 mM coelenterazine for 90 min in DMEM 
supplemented with 1% fetal bovine serum, incubated in KRB (Krebs–Ring modified 
buffer: 125 mM NaCl, 5 mM KCl, 1 mM Na3PO4,1 mM MgSO4, 5.5 mM glucose, 
20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, 378C) 
supplemented with 1 mM CaCl2 and then transferred to the perfusion chamber. When 
indicated, 100 nM bradykinin was added. The experiments were concluded by lysing 
MEFs with 100 mM digitonin in a hypotonic Ca
2+-
rich solution (10 mM CaCl2 in 
H2O), thus discharging the remaining aequorin pool. The light signal was collected in 
a purpose-built luminometer as previously described (Chiesa et al., 2001). 
Mitochondrial Ca
2+
 measurement in PCs 
To measure [Ca
2+
]mito in PCs in primary cerebellar cultures, we created an adeno-
associated viral vector expressing a mitochondria-targeted version of the GFP-based 
Ca
2+
 probe, 4mtD1cpv (Palmer et al., 2006), under the synapsin promoter. 
4mtD1cpv pcDNA3 was used as a template in a PCR with the following primers: 
Primer Forward:  
5’-TTATCGAAATTAATACGACTCACGTGGAATTCGCCACCATGTCCGTCC-
3’ 
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Primer Reverse: 
5’- CCGCCAGTGTGATGGATATCTGCAGAATTCTTA-3’ 
The forward primer was designed to introduce an EcoRI restriction site at the 5’ of 
4mtD1cpv and a Kozak sequence to improve translation efficiency. The PCR product 
was then cloned in the EcoRI site of the pDC511 syn BGH-polyA vector (Montesinos 
et al., 2011). This shuttle plasmid carries the 470 bp human synapsin promoter to 
guaranty neuron specific expression of the cameleon probe. 
Second generation rAd was produced by transfecting E2T cells (Zhou and Beaudet, 
2000) with the genomic helper plasmid (Microbix Biosystems inc., Mississauga, 
Ontario, Canada) that had been modified to contain the E2a deletion and the pDC511 
syn 4mtD1cpv-BGH PolyA vector as previously described (Montesinos et al., 2011). 
Preparation of a high titer viral stock from crude lysate was performed as described in 
Ng and Graham (Ng and Graham, 2002). The titer was determined by limiting 
dilution to have a plaque-forming unit (pfu) of 3.1*10
7 
pfu/ml.  
PCs were transduced at 5 DIV with multiplicity of infection (M.O.I.) of 60 and 
imaged for Ca
2+ 
measurement 72 hours after infection. The FRET data were acquired 
on a Leica TCS SP-5 DS confocal microscope equipped with a 63x NA 1.4 objective. 
(Leica Microsystems GmbH, Wetzlar Germany). The light of a 405 nm solid-state 
laser was used to excite CFP, and the fluorescence emission from both CFP and YFP 
was collected simultaneously using two separate detection channels (CFP 470-505 
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nm and YFP 525-600 respectively). PCs were easily distinguished from granule cells 
and neurons, being markedly bigger and more ramified. Time series of 100 frames 
were collected using an imaging time of 1.314 s/image. After approximately 20 
images 30 mM KCl was added to the imaging medium as described above to quantify 
the mitochondrial calcium response. The FRET signal was quantified by measuring 
the background-subtracted ratio between the YFP and the CFP channels on pixels 
corresponding to mitochondria. 
Cytosolic Ca
2+
 measurement in PCs 
[Ca
2+
]cyto measurements was performed as previously described (Codazzi et al., 
2006). Fura-2 acetoxymethyl ester (Calbiochem, Merck KGaA, Darmstadt, Germany) 
loading was performed at 37°C (4 μM, 40 min) in Krebs Ringer Hepes buffer (KRH, 
containing 5 mM KCl, 125 mM NaCl, 2 mM CaCl2, 1.2 mM MgSO4, 1.2 mM 
KH2PO4 and 6 mM glucose, 20 mM HEPES, pH 7.4). When K
+
 concentration was 
increased in the solution, the concentration of Na
+
 was adjusted to maintain 
isotonicity. Excitation wavelengths of 340 and 380 nm were used with an emission 
wavelength of 510 nm. The 340/380 fura-2 ratio was calculated as mean values 
within regions of interest drawn in neuronal soma. The time course of the intensity 
ratio was analyzed by custom-written routines in MATLAB (The MathWorks Inc., 
Natick, MA, USA).  
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Expression vectors: 
 pcDNA3.1 
 pcDNA3.1-MrpL32-HA 
 pcDNA3.1-Oma1-HA: 
 
OMA1 mouse cDNA clone image was bought from Thermo Scientific (Waltham, 
MA, USA).To introduce an HA tag into c-terminus before the stop codon and the 
XhoI restriction sequence after the stop codon of the purified product, I performed a 
PCR with the following primers: 
FWD: 5'-cacaggaaacagctatgacca-3';  
REV: 5'- tccgctcgagtcaagcgtaatctggaacatcgtatgggtagcctgcagttctcttctctag-3' 
PCR product was purified using “QIAEX II Gel Extraction Kit” (Qiagen) and 
digested with EcoRI and XhoI. The digested product was cloned into pcDNA3.1 
using T4-ligase (Promega) according to the manufacturer’s instruction. 
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 pcDNA3.1-Oma1- (deleted mutants) -HA 
To generate the following constructs I used “QuikChange Site-Directed Mutagenesis 
Kit” by Agilent Technologies (Stratagene Products Division, La Jolla, CA) with the 
appropriate primers. 
construct Primers   
pcDNA3.1-Oma1-E324Q-HA 
 
5'-ttcctcctgggccatcagatcgcacacg-3' 
5'-cgtgtgcgatctgatggcccaggaggaa-3' 
pcDNA3.1-Oma1-Δ147-149-HA 
 
5'-cccagtccctctcttgctgaagccagtgcaaa-3' 
5'-tttgcactggcttcagcaagagagggactggg-3' 
pcDNA3.1-Oma1-Δ150-152-HA 
 
5'-cctctcttgctgctcattgtgcaaaagctccttg-3' 
5'-caaggagcttttgcacaatgagcagcaagagagg-3' 
pcDNA3.1-Oma1-Δ153-155-HA 
 
5'-ctgctcattctgaagccactccttgctatcatcgtg-3' 
5'-cacgatgatagcaaggagtggcttcagaatgagcag-3' 
pcDNA3.1-Oma1-Δ170-HA 
 
5'-gcataaggaaatggtgggcacttccccctaacaa-3' 
5'-ttgttagggggaagtgcccaccatttccttatgc-3' 
pcDNA3.1-Oma1-Δ171-HA 5'-ataaggaaatggtggcaacttccccctaacaagaag-3' 
5'-cttcttgttagggggaagttgccaccatttccttat-3' 
pcDNA3.1-Oma1-Δ172-HA 
 
5'-gcataaggaaatggtggcaagcaccccctaacaag-3' 
5'-cttgttagggggtgcttgccaccatttccttatgc-3' 
pcDNA3.1-Oma1-Δ169-172-HA 
 
5'-ggggcataaggaaatggccccctaacaagaagg-3' 
5'-ccttcttgttagggggccatttccttatgcccc-3' 
pcDNA3.1-Oma1-Δ173-176-HA 
 
5'-gggcataaggaaatggtggcaagcacttaaggagctatttaaa-3' 
5'-tttaaatagctccttaagtgcttgccaccatttccttatgccc-3' 
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pcDNA3.1-Oma1-Δ175-178-HA 5'-ggcaagcacttccccctctatttaaagacagcgt-3' 
5'-acgctgtctttaaatagagggggaagtgcttgcc-3' 
pcDNA3.1-Oma1-Δ177-180-HA 
 
5'-cacttccccctaacaagaaagacagcgtgaggaa-3' 
5'-ttcctcacgctgtctttcttgttagggggaagtg-3' 
 
 pcDNA3.1-Oma1-Δ92-144-HA 
To generate the construct pcDNA3.1-Oma1-Δ92-155-HA we used this clone 
strategy: 
1) pcDNA3.1-OMA1-HA was digested by EcoRI and XhoI and purified using 
the appropriate Qiagene kit. Two different PCR were performed to obtain two 
OMA1 fragments.  
2) I used the universal primer T7 forward and 
5’AATGAGCAGCAAGAGGGTAAGCACCCCCAATTCC-3’ to clone 
OMA1 amino acid region from the first to the 91
th
 amino acid.  Then, I 
performed a PCR with 5’-
TTGGGGGTGCTTACCCTCTTGCTGCTCATTCTGAAG-3’ and the 
universal primer BGHrev to clone the amino acid region from 145 to 521. 
3) The two pcr products were purified using “QIAquick PCR Purification Kit” 
by Quiagen. The two purified products were ligated using T4 ligase 
(promega) according to the manufacturer’s instruction. 
4)  This products were digested using EcoRI and XhoI and cloned in pcDNA3.1 
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 PcDNA3.1-AFG3L2-myc 
 PcDNA3.1-AFG3L2-E575Q-myc 
 PcDNA3.1-AFG3L2-E408Q-myc  
These three constructs were already present and used in our laboratory(Koppen et al., 
2007), but to overexpress them in the presence of the specific Stealth RNAi against 
AFG3L2 we needed to mutagenize them to generate insensitive Stealth RNAi 
constructs. For this reason we modified the last base of 4 codons in the region 
recognized by the Stealth RNAi. To perform this mutation we used the QuikChange 
Site-Directed Mutagenesis Kit” by Agilent Technologies with this specific primers: 
FWD: 5'-ctatctttcaaaaggagtagtagaccgcctagaagtcgtcaacaagcgttttgttc-3' 
REV: 5'-gaacaaaacgcttgttgacgacttctaggcggtctactactccttttgaaagatag-3. 
 
 pMT21-YME1L1-E543Q-myc (isoform 3) 
pMT21-YME1L1-MYC was mutagenized to generate the proteolytic inactive 
form. To do this I used “QuikChange Site-Directed Mutagenesis Kit” by 
Agilent Technologies with this specific primers: 
5'-ataatggcatgaccagactgatgatatgctgtgatggttttgtttttgttat-3' 
5'-ataacaaaaacaaaaccatcacagcatatcatcagtctggtcatgccattat-3'  
To overexpress them in the presence of the specific Stealth RNAi against 
YME1L1 we needed to mutagenize them to generate insensitive Stealth RNAi 
constructs. We used the same stratege describe above with these primers: 
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5'-agaaggattcttatttcttgttcgattgcggactgagtttctggacttagtttccctgtatc-3' 
5'-gatacagggaaactaagtccagaaactcagtccgcaatcgaacaagaaataagaatccttct-3' 
 
The fidelity of all constructs was confirmed by automated DNA sequencing. 
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Biochemical assay 
Protease inhibitors experiment  
HeLa cells were transfected overnight with pcDNA3.1 OMA1-HA and 14 h after 
transfection they were incubated for 10 h with the following protease inhibitors: 0.5 
mM o-phe, 100 µM E-64d and 400 µM PMSF (Sigma-Aldrich) 
 
Uncoupler treatment  
HeLa cells were treated with Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
(FCCP)( Sigma Aldrich ) 10 µM for the indicated time points. 
  
Western blot analysis 
Western blot was performed using standard protocols. Briefly, total cell lysate was 
prepared by protein extraction using a Triton-containing buffer (50 mM Tris-HCl pH 
8, 150 mM NaCl, 2% Triton, 0.5 mM EDTA pH 8, 1X Protease Inhibitor Cocktail, 
Roche Applied Science). The protein concentration was evaluated using Quick 
Start™ Bradford Protein Assay.( Hercules, CA, United States of America).  25 µg of 
protein extracts were dissolved in Sample buffer (60 mM Tris-HCl pH 6.8, 5% 
glycerol, 1,7% SDS, 0,1 M DTT, 0,002% bromophenol blue), were separated on 
SDS-PAGE and analyzed by standard immunoblotting procedures.  
Co-immunoprecipitation  
Co-transfected HeLa cells were lysate after 24h from transfection with buffer A (50 
mM Tris HCl ph 8.00, 150mM NaCl, 0.5mM EDTA ph8, 1X Protease Inhibitor 
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Cocktail, 0.15% Sarkozyl- 30’- 4°C). At the end of the incubation the lysate was 
sonicated. The soluble fraction was recovered after centrifugation (13.000 rpm - 10’ 
at 4°C). Supernatant represent the soluble fraction and it is quantified by Quick 
Start™ Bradford Protein Assay (Bio-Rad, city and country). 1000 µg of lysate 
underwent to pre-clearing step to reduce nonspecific binding of proteins to sepharose. 
For this reason recombinant Protein G Sepharose beads were incubated in buffer B  
(50 mM Tris HCl ph 8.00, 150mM NaCl, 0.5mM EDTA ph8, 1X Protease Inhibitor 
Cocktail, 0.03% Sarkozyl ) for 30 at 4°C  and then incubated 1h with the lysate. After 
this step, beads were precipitated by centrifugation (1200 rpm- 5’- 4°C) and 
discarded. Supernatant was incubated with the anti-Myc antibody for an hour in 
constant gentle agitation. Before adding protein G Agarose beads to the lysate, they 
have to be incubated in buffer B  (50 mM Tris HCl ph 8.00, 150mM NaCl, 0.5mM 
EDTA ph8, 1X Protease Inhibitor Cocktail, 0.03% Sarkozyl) within gentle agitation 
for 30’- 4°C. Then beads were added to the lysate for 1h at 4°C in constant 
suspension. In the end, beads were precipitated by centrifugation (1200 rpm- 5’-4°C) 
and washed three time with the buffer C  (50 mM Tris HCl ph 8.00, 150mM NaCl, 
0.5mM EDTA ph8, 1X Protease Inhibitor Cocktail, 0.015% Sarkozyl ). Precipitates 
were used for Western blot analysis. 
For the reverse Co-Ip (immunoprecipitation OMA1-HA and detection AFG3L2) 
1000 µg of lysate underwent to pre-clearing step, then the supernatant was incubated 
with HA.11 Clone 16B12 Monoclonal Antibody, Affinity Matrix  beads (Covance, 
Princeton, New Jersey, USA) that have been previously incubated in buffer B for 30’ 
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at 4°C. The incubation between lysate and conjugated HA sepharose beads occurred 
for 1 h at 4°C in constant gentle agitation. At the end of the incubation, beads were 
treated as before. 
Mitochondrial isolation 
Mitochondria were isolated from HeLa cells according to manufacturer's protocol 
(Pierce) with minor modifications. Briefly, the cells were trypsinized and harvested. 
A Dounce homogenizer was used to lyse the cells by 40 strokes. After removing the 
nuclear fraction (centrifugation of total lysate at 2500 rpm for 10 minutes at 4°C) , the 
crude supernatant was spun at 13,000 rpm for 25 minutes to pellet the intact 
mitochondria. The mitochondrial pellet was resuspended in Mitochondrial buffer 
(0.25M sucrose, 20 mM MOPS, 1mM EDTA, and 1X protease inhibitor cocktail 
(Sigma) to collect mitochondrial proteins. For each fractionation, equal amounts of 
soluble cytosolic protein and mitochondrial protein were determined by BCA assay 
(Pierce). 
Proteinase proteolysis assay 
Mitochondria were isolated by the mitochondrial isolation protocol described above. 
The mitochondrial pellet was resuspended in Mitochondrial buffer (0.25M sucrose, 
20 mM MOPS, 1mM EDTA) and aliquoted into equal fractions. Final concentration 
of 50/100 μg/mL of trypsin was added to the appropriate sample tube with or without 
a final concentration of 1% Triton X-100. Samples were incubated on ice for 30 
minutes and the proteolysis was inhibited by the addition of PMSF and protease 
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inhibitor cocktail. Then the samples were centrifuged at max speed for 5 minutes and 
the pellet was resuspended in Sample Buffer. Proteins were resolved on SDS-PAGE. 
Mitochondrial import inhibition 
Hela cells were transfected with the indicated plasmids. After 10 hours from the 
transfection, the cells were treated with valinomycin 1µM or valinomycin + Mg 132 
(2.5 µM) for 16 hours. Subsequently, the mitochondrial isolation described above was 
performed.   
Transient transfection  
Transient transfection for the overexpression or for the silencing was performed using 
LIPOFECTAMINE 2000 (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s instructions.  
 
Down-regulation 
Down-regulation of AF3GL2, OMA1 and YME1L1 was performed using specific 
Stealth RNAi and the non-targeting Stealth RNAi negative control (Invitrogen).  
The sequences are 5’-ACGACUUCCAAUCUGUCUACUACUC-3’ for human 
AFG3L2, 5’-UGGACUACUGCUUGCUGCAAAGGCU-3’ for human OMA1,                                                         
5'-UCCAGAAACCCAAUCUGCCAUCGAA-3’ for human YME1L1.  
100 pmoles of each siRNA were transfected using Lipofectamine (Invitrogen). 
Down-regulation of the target gene was monitored by Immunoblot analysis on cell 
lysates after 48h/72 h from transfection. 
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Densitometry analysis  
To perform densitometry a of Western Blot bands I used the specific plug in of 
ImageJ. 
 
Statistical analyses 
Results are reported as the mean ± SEM. Most of the experiments were evaluated by 
Student’s t test. Chi squared test with 2 degrees of freedom was applied for analysis 
of ultrastructure of mitochondria. 
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RESULTS  
Part I: AFG3L2 deficiency impairs mitochondrial Ca
2+
 buffering, causes 
organellar network fragmentation and Purkinje Cells degeneration. 
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Afg3l2 ko cells show increased mitochondrial fragmentation  
 
It was previously demonstrated in the lab that the absence of AFG3L2 induces severe 
alterations of the mitochondrial structure and function: in particular the 
disorganization of cristae structure, the alteration of respiratory chain complex I and 
complex III assembly, the increase in the amount of reactive oxygen species and the 
decrease in ATP production (Maltecca et al., 2008; Maltecca et al., 2009). Starting 
from these findings, we evaluated if the absence of AFG3L2 could cause an alteration 
in the mitochondrial network morphology.  To achieve this goal we performed live 
imaging in MEF cells overexpressing a mitochondria-targeted yellow fluorescent 
protein (mt-YFP). Cells were divided into three classes accordingly to mitochondria 
shape: tubular mitochondrial network, intermediate or fragmented mitochondrial 
structures (Ishihara et al., 2006). We observed an evident alteration in mitochondrial 
network morphology in Afg3l2 ko cells. Indeed, morphometric analysis demonstrated 
that wild-type and heterozygous MEFs have fused mitochondria. In contrast, Afg3l2 
ko cells showed more than 50% of cells with fragmented mitochondria and only 5% 
of cells with a tubular mitochondrial network (Fig. 1) (Maltecca et al., 2012).  
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Figure 1:the absence of AFG3L2 induces mitochondrial network fragmentation. 
 
A) Representative pictures of mitochondrial morphology in Afg3l2 MEFs transfected with mt-YFP and 
visualized by confocal microscopy. (B) Morphometric analysis of mitochondrial morphology in 
Afg3l2 MEFs. One hundred and fifty randomly selected cells were analyzed in each experiment. Bars 
represent means+SD of three independent experiments. The Chi-squared test (2 degrees of 
freedom): Afg3l2 ko versus either heterozygous or wild-type MEFs = P ,0.001. (C) 
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Fission of the mitochondrial network in Afg3l2 ko MEFs reduces organellar 
matrix continuity and leaves a fraction of mitochondria devoid of connection to 
the ER 
 
The Afg3l2 haploinsufficient mouse resembles the phenotype of SCA28 patients, 
showing a progressive decline in motor performances caused by PC-DCD (Maltecca 
et al., 2012). We hypothesize that AFG3L2-depleted mitochondria have defective 
Ca
2+
 buffering capacity, leading to dysregulation of cytosolic Ca
2+
 homeostasis and 
finally to PC-DCD. We evaluated whether the mitochondrial fragmentation observed 
in Afg3l2 ko cells could impact on mitochondrial Ca2+ buffering. In particular we 
wondered whether mitochondrial altered morphology could influence the number of 
mitochondria/ER contacts, specialized sites where IP3R/RyR mediated 
Ca
2+
oscillations are propagated locally to the mitochondria. The close vicinity of 
mitochondria to Ca
2+
 release sites on the ER is crucial for the activation of the MCU 
and thus for the rapid and efficient accumulation of Ca
2+
 inside the organelles 
(Csordas et al., 2010; Rizzuto et al., 1998). To measure the total number of contacts 
in the whole cell volume, we analyzed the colocalization between mitochondria and 
ER with three-dimensional (3D) reconstruction and volume rendering of confocal 
stacks of ER-targeted green fluorescent protein (ER-GFP) and mitochondrial-targeted 
red fluorescent protein (mt-RFP) in the three genotypes, as previously reported 
(Nicholls, 1974) (De Brito and Scorrano, 2008) (Fig. 2A) . In this analysis, we 
considered the overlapping mitochondrial and ER spots as the sites where most-
efficient Ca
2+
 transfer between the two organelles occurs, thus satisfying the high 
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Ca
2+
 concentration demand for the opening of the MCU. As measured by Manders’ 
colocalization coefficient (Manders, 1993), we found that the evident fragmentation 
of the mitochondrial network does not affect the average number of mitochondria-ER 
contact sites in Afg3l2 ko cells (Fig. 2B) Similarly, the overall volume of the 
organellar network of  both mitochondria and ER is unaffected by the loss of 
AFG3L2, as demonstrated by quantitative morphological imaging of the 
mitochondrial and ER networks by transfecting cells with mt-RFP or ER-GFP, 
respectively. After 3D reconstruction of confocal stacks, the images were analyzed 
evaluating the total volume of the organellar network. ER architecture was unaffected 
by the loss of AFG3L2, appearing as an interconnected network of cisternae spanning 
the whole cellular volume. We also observed that fragmentation of the mitochondrial 
network does not alter either the mitochondrial or the ER total volume, the ratio of 
the two organellar volumes being comparable in the three genotypes (Fig. 2C). 
According to the observed fragmentation, we found a significant reduction in the 
average size of individual mitochondrial particle in Afg3l2 ko cells compared with 
controls (6.94+2.3 versus 12.68+3.35 mm
3
 in wild-type and 12.3+1.91 mm
3
 in 
heterozygous cells, P , 0.001) (Fig. 2D). Having the  cell lines the same mitochondrial 
total volume, these data indicate that Afg3l2 ko cells have an increased number of 
individual mitochondria compared to wild-type and heterozygous cells (Fig. 2E). This 
hypothesis was verified by counting the total number of RFP-positive objects per cell, 
which is almost doubled in Afg3l2 ko cells compared with control cells, while the 
percentage of objects that are in contact with the ER is reduced (Fig. 2F).  
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Figure 2: Mitochondrial fragmentation leaves a fraction of organelles free of connections to the 
ER.  
Mitochondrial fragmentation leaves a fraction of organelles free of connections to the ER. (A) 
Representative images of Afg3l2 knockout, heterozygous and wild-type MEFs cotransfected with ER-
GFP and mt-RFP. Insets show 3D reconstructed confocal stacks. (B) Quantitative analysis of ER-
mitochondria colocalization estimated by Manders’ coefficient. (C-D) Effect of Afg3l2 depletion on 
total mitochondrial volume and on individual mitochondrial particles, respectively. (E-F) 
Quantification of the total number of RFP-positive objects and quantification of the percentage of 
RFP-positive objects in contact with the ER in the three genotypes. Data were obtained from an 
average of 60 randomly selected cells per genotype. Bars represent means+SD of three independent 
experiments. Student’s t-test: ∗P <0.05,   
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Loss of AFG3L2 causes reduced mitochondrial Ca
2+
 uptake 
 
To examine the effect of the loss or haploinsufficiency of Afg3l2 on mitochondrial 
Ca
2+
 buffering, we performed Ca
2+ 
measurements on MEFs by employing aequorin 
chimeras targeted to mitochondria and cytosol compartments (mtAEQmut and 
cytAEQ) (Chiesa et al., 2001). Cells were challenged with bradykinin, which leads to 
an inositol (1,4,5)triphosphate-triggered release of Ca
2+
 from the ER stores and its 
accumulation in the mitochondrial matrix. In Afg3l2 ko cells, the mitochondrial Ca2+ 
peak response ([Ca
2+
]m) elicited by bradykinin stimulation was strongly reduced 
compared with Afg3l2 heterozygous and wild-type cells, as measured by the low-
affinity mtAEQmut probe (Fig. 3A). The decreased mitochondrial Ca
2+
 response in 
Afg3l2 ko cells was specific of mitochondria and not secondary to global cellular Ca2+ 
signaling. In fact, cytosolic Ca
2+
 response ([Ca
2+
]c) measured by the cytAEQ probe 
after bradykinin stimulation revealed no alterations in Afg3l2 ko cells compared with 
wild-type cells (Fig. 3B). These experiments demonstrate that Afg3l2 null 
mitochondria show decreased average [Ca
2+
]m elevations in the presence of a 
maximal Ca
2+
stimulation demonstrating that the mitochondrial network induces 
strong defect in Ca
2+ 
homeostasis.  
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Figure 3: Loss of Afg3l2 reduces mitochondrial Ca
2+ 
uptake. 
(A and B) [Ca
2+
]
m
 and [Ca
2+
]
c
 in Afg3l2 MEFs of the indicated genotypes measured by aequorin probes 
(mtAEQmut and cytAEQ). On the left: representative graphs; on the right: means+SD of [Ca
2+
]
m
 and 
[Ca
2+
]
c 
peak responses after bradykinin stimulation, respectively (16 traces obtained from four 
independent experiments). Student’s t-test: ∗∗P< 0.001, ∗P <0.05.  
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Loss of AFG3L2 in primary Purkinje cells induces mitochondrial morphological 
alterations and depletion of dendritic mitochondria 
Considering the limitation represented by non-excitable and non-polarized cells such 
as fibroblasts, we decided to test mechanism of pathogenesis for SCA28 in cultured 
primary PCs. In fact, these are the neurons primary affected in SCA28 patients. We 
first performed a quantitative evaluation of PC morphology by IF using anti-calbindin 
antibody at 14 days in vitro (DIV). Afg3l2 heterozygpus PCs appeared comparable to 
wt, while in Afg3l2 ko PCs dendrites were slightly decreased in number and in length 
but considerably reduced in terms of area, appearing thinner with shorter side 
branches (Fig.4 A-B). Then, we examined the morphology, the distribution and the 
metabolic status of mitochondria in primary PCs. We first performed IF and confocal 
microscopy using an antibody against COX1 (mitochondrial marker) and against 
calbindin (PC marker). In Afg3l2 ko PCs, mitochondria were mostly round shaped as 
we previously observed in MEFs (Maltecca et al., 2012), in contrast with the tubular 
shaped organelles observed in syngenic controls (Fig. 4A). We also investigated 
whether alterations of mitochondrial morphology may alter the trafficking of the 
organelles to the distal dendritic branches of PCs. By three-dimensional (3D) 
reconstruction of confocal stacks of PCs stained with anti-calbindin and anti-COX1 
antibodies, we analyzed the mitochondrial volume in the whole PC volume and in 
dendrites. We observed that the total volume of mitochondria is not changed in 
Afg3l2 ko PCs, though these cells contain fewer mitochondria in their dendrites (Fig. 
4C-D).  
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To further address a defective trafficking of mitochondria, we assayed mitochondria 
ultrastructure by electron microscopy (EM). In wt PCs, mitochondria are evenly 
distributed in the cell soma and in dendrites, have structurally intact inner and outer 
membranes with well-defined cristae and show tubular shape. On the contrary, in 
Afg3l2 heterozygous PCs we observed a remodeling of the inner membrane 
conformation ranging from widening to vesiculation of the cristae, which worsens 
dramatically in Afg3l2 ko PCs, where most of the organelles appear swollen (Fig. 
4E). Quantification of these alterations is reported in (Fig. 4F). Consistent with 
confocal microscopy observations, in Afg3l2 ko PCs mitochondria aggregated in the 
soma leaving dendrites depleted of organelles. No differences in mitochondrial 
distribution were apparently detected in Afg3l2 heterozygous PC-dendrite compared 
to wt, indicating that organellar morphological alterations may be not so severe to 
hamper the entry of the organelles into the dendritic tree, at least in culture 
conditions. 
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Figure 4: Loss of Afg3l2 in PCs alters dendritic mitochondrial content and the mitochondrial 
shape. 
(A)IF on primary PCs of the indicated genotypes at 14 DIV using antibodies against the PC marker 
calbindin and the mitochondrial marker COX1 analyzed by confocal imaging. (B) Quantification of 
the area of dendrites [means +/- SD, n=6, +/-20 neurons analyzed/experiment; student’s t test: **p< 
0.001]. (C and D) Quantification of the total mitochondrial volume relative to the total PC volume (C) 
or relative to PC dendrite volume (D) analyzed by 3D reconstructon of consecutive confocal stacks 
taken at 0.3 μm (n=15 PCs analyzed per genotype). Student’s t test: **p< 0.001. EM on primary PCs at 
14 DIV. Arrowheads indicate aberrant mitochondria. (B) Quantification of mitochondrial 
ultrastructural alterations. The organelles were classified as normal, vesicular and swollen on the basis 
of inner membrane remodeling. The graph indicates means  SD of an average of 200 mitochondria 
from 5 cells in 3 independent experiments. Chi squared test (2 degrees of freedom): Afg3l2 ko versus 
either Afg3l2
 
heterozygous or wild-type PCs p< 0.001, wt versus Afg3l2
+/-
 p< 0.05.  
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Loss of AFG3L2 in Purkinje cells results in reduced mitochondrial Ca
2+
 uptake 
and increased cytosolic Ca
2+
 concentration 
 
In the SCA28 mouse, PC-DCD originates from mitochondrial dysfunction (Maltecca 
et al., 2009). Since PCs are exposed to massive Ca
2+
 influx (Ito, 2002) and 
mitochondria can transiently store large amount of Ca
2+
(Duchen, 2012; Pizzo et al., 
2012), we reasoned that a defective Ca
2+
 buffering operated by Afg3l2-mutant 
mitochondria in PCs could increase [Ca
2+
]cyto and cause DCD, thus mimicking 
excitotoxicity. 
To measure [Ca
2+
]mito in PCs in primary cerebellar cultures, we created an adeno-
associated viral vector expressing a mitochondria-targeted version of the GFP-based 
Ca2+ probe, 4mtD1cpv (Palmer et al., 2006), under the synapsin promoter. 
Transduction of this probe in primary cerebellar cultures gave neuron-specific signal. 
Among the various neuronal types, PCs were easily distinguished in bright field, 
being markedly bigger and more ramified compared to granule cells. Upon challenge 
with 30 mM KCl, which depolarizes the plasma membrane in neurons by opening 
potential-sensitive Ca
2+
 channels, mitochondrial Ca
2+
-rises of transduced neurons 
were significantly smaller in Afg3l2 ko PCs compared to Afg3l2 heterozygous and wt 
cells (Fig. 5 A-B).  
In parallel, we performed ratiometric measurement of [Ca
2+
]cyto in PCs
 
employing the 
high affinity Ca
2+ 
indicator fura-2. The basal levels of [Ca
2+
]cyto were identical in the 
three genotypes. On the contrary, we observed that in Afg3l2 ko PCs, the peak of Ca2+ 
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response elicited by acute exposure to 30 mM KCl was significantly higher compared 
to Afg3l2
 
heterozygous and wt PCs (Fig. 5C).This result demonstrates that the 
inefficient mitochondrial Ca
2+ 
buffering in Afg3l2ko PCs causes an abnormal 
cytosolic Ca
2+
 elevation 
   
 
Figure 5: Reduced mitochondrial Ca
2+
 
uptake in the absence of AFG3L2 results 
in increased [Ca
2+
]cyto. 
 (A) Representative traces of evoked-
[Ca
2+
]
mito
 responses in PCs expressing 
4mtD1cpv. (B) Means  SEM of [Ca
2+
]
mito
 
peak responses
 
after KCl stimulation 
(normalized increase in YFP/CFP ratio 
measured above the initial value; n=4, 20 
traces analyzed/experiment). Student’s t 
test: *p< 0.05, **p< 0.001 (C) Means  
SEM of [Ca
2+
]
cyto
 peak responses
 
after 30 
mM KCl stimulation (normalized increase 
measured above the initial value, n=5, 15 traces analyzed/experiment). Student’s t test: ** p< 0.001.  
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Part II: A protease chain reaction functionally links AFG3L2 to OMA1, OPA1 
and finally to mitochondrial fragmentation. 
  
Results  
92 
 
The absence of AFG3L2 induces fragmentation through OMA1-mediated OPA1 
processing  
Demonstrated the importance of mitochondrial morphology in SCA28 pathogenesis, 
we wanted to understand which molecular pathway is involved in mitochondrial 
fragmentation in the absence of AFG3L2. To discriminate if mitochondrial network 
fragmentation was caused by an increase in fission or a decrease in fusion, we 
decided to analyze DRP1 localization and OPA1 processing. As described in the 
introduction, DRP1 is a cytosolic protein that can interact with its receptor Fis1 on 
mitochondria, inducing fragmentation. To verify if the absence of AFG3L2 could 
activate DRP1 re-localization we performed sub-cellular fractionation of Afg3l2 wt 
and ko MEF; we didn’t observe any difference among the genotypes (Fig. 6A). This 
allows us to conclude that the mitochondrial fragmentation observed in the absence of 
AFG3L2 does not involve DRP1 activation and therefore is not due to increased 
mitochondrial fission. We thus focused our investigations on the mitochondrial fusion 
process and, in particular, we analyzed OPA1 processing. OPA1 is a pro-fusion 
protein that exists in several isoform deriving from alternative splicing. These 
isoforms are processed in accordance to their proteolytic cleavage sites. By Western 
blot analysis, OPA1 is detected as 5 different bands: two long bands called L1 and L2 
and three short bands called S1-S2-S3. In healthy conditions there is a balance 
between OPA1 long and short forms, whereas in stress conditions, an increase in 
short forms is observed parallel to mitochondrial fragmentation.  
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The analysis of OPA1 band pattern in wild-type, Afg3l2 heterozygous and Afg3l2 ko 
cells by Western blot revealed that the loss of AFG3L2 results in alteration of OPA1 
processing: in the absence of AFG3L2 we detected an increased amount of cleaved 
OPA1 forms and the almost-complete disappearance of the long bands (Fig. 6B). No 
apparent differences were observed between Afg3l2 wild- type and heterozygous 
cells, indicating that Afg3l2 haploinsufficiency does not affect OPA1 processing and 
mitochondrial morphology in this cellular system. We observed the alteration of 
OPA1 processing even in tissues coming from the CNS of Afg3l2 ko mouse (Fig. 
6C). The increased OPA1 processing in absence of AFG3L2 was demonstrated to be 
correlated to the activation of OMA1, a protease of the IMM (Ehses et al., 2009). 
However, the relationship between the absence of AFG3L2 and the overactivation of 
OMA1 has not been identified yet.  
We decided to study OMA1 regulatory pathway to clarify if AFG3L2 has a role in 
OMA1 activation. It has been published that OMA1full length is 60 kD while the 
identified active form of the protein has a molecular weight of 40 kD, but nothing is 
known about the protease involved in this cleavage. Moreover, it has been 
demonstrated that OMA1 is activated during stress condition as ATP depletion or 
increased ROS production.  So, we wanted to clarify if AFG3L2 could be directly 
involved in OMA1 processing mediating OMA1 cleavage from 60 to 40 kD or 
indirectly, since the absence of AFG3L2 induces the environmental stress (ATP 
depletion or increased ROS production) that acts OMA1. 
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Figure 6: Mitochondrial fragmentation in the absence of AFG3L2 is caused by OPA1 
overprocessing:  
A) Immunoblot analysis of total cell extracts, cytosolic fraction and mitochondrial fraction from 
Afg3l2 wt and ko MEFs detected with antidodies agains Drp1, TIM44 and Tubulin. TIM44 antibody 
was used as mitochondrial marcker, while tubulin as cytosolic marker 
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(B-C) Immunoblot analysis of total cell extracts from Afg3l2 MEFs or neuronal tissues of the indicated 
genotypes . The five OPA1 bands are indicated as long (L1 and L2) and short isoforms (S1, S2 and S3) 
(30). Hsp60 and tubulin were used to verify equal loading, respectively.  
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OMA1 processing occurs inside the inner mitochondrial membrane  
To perform our studies deals with OMA1 regulation, we transfected an OMA1-HA 
form in HeLa or MEFs. We needed to use the overexpression condition since the 
commercial antibodies against OMA1didn’t work in biochemistry. OMA1 -HA in 
Western blot appeared in three major bands; a first band at 60 kD representing the full 
length protein, a band at 40 kD proposed to be the active one and a doublet around 25 
kD generated by autocatalytic process. These three bands were previously described 
in literature (Baker et al., 2014; Head et al., 2009); but we were the first group able to 
detect the three major OMA1 bands contemporary. This is an important point since 
we wanted to clarify the regulatory pathway of OMA1. 
To clarify the mechanism involved in OMA1 40 kD generation we started 
individuating the cellular localization of this process. To understand whether OMA1 
40 kD generation occurs in the cytosol or in the mitochondrion we transfected HeLa 
cells with an HA tag form of OMA1 and treated them with a mitochondrial import 
inhibitor (Valinomycin) alone or in combination with the proteasome inhibitors 
MG132. Western blot analysis on mitochondrial and cytosolic enrichments 
demonstrated that OMA1 40 kD form is present only in the mitochondrial fraction; 
this band disappears when mitochondrial import is inhibited (Fig. 7A). To determine 
in which sub-mitochondrial compartment OMA1 40 kD is generated, we combined 
digitonin extractions with protease digestions. Digitonin disorganizes the outer 
membrane, making intermembrane space proteins accessible to cleavage by 
exogenously added proteases such as trypsin. As a control, protease sensitivity of the 
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integral protein TIM23 of the inner mitochondrial membrane was assessed. OMA1 40 
kD was digested in the presence of digitonin, at the same manner of TIM23 
indicating that OMA1 40 kD form, is exposed to the intermembrane space. On the 
other hand the soluble matrix protein HSP60 was less affected by trypsin in this 
condition (Fig. 7B). We concluded that the processing of OMA1 from 60 to 40 kD is 
mediated by an inner membrane protease.  
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Figure 7: OMA1 60/40 kD process occurs in the inner mitochondrial membrane . 
(A)Immunoblot analysis of total cell extracts, cytosolic fraction and mitochondrial fraction from HeLa 
cells transfected with OMA1-HA. Cells were treated over-night with Valinomycin 1 µM (V) or 
Valinomycin 1 uM+ MG132 2,5 µM (V+M). The membrane was immunodecorated with antibodies 
against HA, GAPDH and Porin.  Porin antibody was used as mitochondrial marcker, while tubulin as 
cytosolic marker. (B) Immunoblot analysis of mitochondrial fraction from HeLa cells transfected with 
OMA1-HA. Or empty vector (E.V.) isolated mitochondria were treated with the indicate concentration 
of digitonin or/and trypsin. The membrane was immunodecorated with antibodies against HA, 
(MFN2), TIM 23, TIM44 and HSP60. MFN2 was used as OM protein marker, TIM23 as IMM 
integrated protein  marker, TIM44 as MM associated protein  markerand Hsp60 as matrix protein 
marker. 
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A metallopeptidase is responsible for the 60/40 kD processing of OMA1 
 
To discover the peptidase(s) involved in OMA1 40 kD generation we transfected 
HeLa cells with OMA1-HA, incubated them with several peptidase inhibitors and 
monitored the accumulation of the 60 kD band. We used PMSF to inhibit serine 
proteases, E64 for cysteine proteases and O-phenantroline (O-phe) to block 
metallopeptidases. By this approach, we observed that O-phe was able to induce the 
accumulation of the 60 kD form, indicating metallopeptidase as the class of proteins 
involved in this mechanism (Fig. 8). Using bioinformatics approach we selected 380 
putative mitochondrial proteases coming from four different protein databases: 
UniProt (UniProtConsortium), MitoCarta (Pagliarini et al., 2008) , MitoMiner (Smith 
and Robinson, 2009) and Gene Onltology (Ashburner et al., 2000). We selected all 
the metallopeptidase, or other proteins working using metallo-ions and then we 
screened them using MEROPS database (Rawlings et al.). This last database helped 
us to individuate all the proteases inhibited by O-phe and we identified 72 proteases. 
Nevertheless, a high percentage of these 72 proteins didn’t show any experimental 
data supporting their mitochondrial localization but only an in-silico prediction. To 
avoid false positive results, we decided to take in consideration only those proteins 
for which mitochondrial localization was reported in at least two databases; with this 
criterion we determined 27 proteins. Among them we excluded all the proteins 
inhibited by metallo-ions, acting in a consensus sequence not present in OMA1 or 
showing deacetylase/hydrolase features still present in the list. Finally we selected 4 
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proteins localized in the IMM since this is OMA1 localization and proteolytic site 
(scheme A) (Tab. 1). These four proteins are: OMA1, paraplegin, AFG3L2 and 
YME1L1. 
 
 
Figure 8: A metallopeptidase cleaves OMA1 from 60 to 40 kD. 
Immunoblot analysis of total extracts from HeLa cells treated for 5 hours with DMSO, O-phe, E-64, 
PMSF detected with the indicated antibodies. 
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OMA1 60 kD form accumulates in the absence of AFG3L2 
 
Among the four selected proteins OMA1 itself is present in the list. OMA1 is a 
metallopeptidase belonging to the M48 subclass (Kaser et al., 2003). In agreement to 
what reported by Head and colleagues (Head et al., 2009), we observed that the 
overexpression of the proteolytic inactive mutant of OMA1 (OMA1 E324Q-HA) 
doesn’t induce an accumulation of the 60 kD band, thus excluding a direct role of 
OMA1 in the generation of the 40 kD. On the other hand the bands around 25 kD 
totally disappeared (Fig. 9A) confirming the auto-processing described by Baker at al. 
(Baker et al., 2014). Interestingly, the overexpression of OMA1-E324Q-HA was able 
to affect the autocatalytic process but not OMA1-mediated OPA1 processing (Fig. 
9B). We conclude that the endogenous OMA1 is able to perform its activity on 
OPA1. This indicates that OMA1-mediated OPA1 processing is extremely well 
regulated. 
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Figure 9: OMA1 performs an autocatalytic cleavage on the C-Term. 
(A-B) Immunoblot analysis of total extracts from HeLa transfected with OMA1-HA, OMA1-E324Q-
HA or Empty Vector (E.V) detected with the indicated antibodies. 
(C): Quantification of ratio between OPA1 long and short forms after over-expression of OMA1-HA, 
OMA1-E324Q-HA or E. V. 
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We then analyzed the possible role of paraplegin in the generation of OMA1 40 kD 
form. Transfecting OMA1-HA in SPG7
-/-
 human immortalized fibroblasts we didn’t 
find any alteration in OMA1 processing compared to wt (Fig. 10). This result 
excludes paraplegin as the protease involved in OMA1 40 kD generation and it is in 
line with unaltered OPA1 processing in the absence of paraplegin (Ehses et al., 2009).  
 
 
 
Figure 10: Paraplegin is not involved in OMA1 60/40 kD processing. 
Immunoblot analysis of total extracts from immortalized human fibroblast SPG7 wt and ko transfected 
with OMA1-HA and detected with the indicated antibodies. 
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We then evaluated OMA1 processing in Afg3l2 ko MEFs; we found that the absence 
of AFG3L2 induces a marked accumulation of the 60 kD band and a reduction of the 
40 kD (Fig. 11A). To have a further evidence of the role of AFG3L2 in OMA1 
processing, we tested the accumulation of the 60 kD band also in HeLa cells silenced 
for AFG3L2 (Fig. 11B). HeLa cells, which differently from murine cells do not 
express the AFG3L2 homologus AFG3L1, behave similarly to Afg3l2 ko MEFs when 
AFG3L2 is knocked down showing the accumulation of the 60 kD band (Fig. 11). 
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Figure 11: AFG3L2 performs 60/40 kD OMA1 cleavage. 
(A) Immunoblot analysis of total extracts, from Afg3l2 MEFs and HeLa cells transfected with OMA1-
HA or E.V. and detected with the indicated antibodies. Quantification of ratio between OMA1 60/40 
kD band  
(B) Immunoblot analysis of total extracts, from HeLa cells knocking down for AFG3L2 and 
transfected with OMA1-HA or E.V. Membrane was immunodecorated with the indicated antibodies.  
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AFG3L2 physically interacts with of OMA1  
 
The inefficient conversion from 60 kD to 40 kD in the absence of AFG3L2 can be 
explained by a direct or an indirect cleavage. In fact, or AFG3L2 is the directly the 
protease that mediates OMA1 cleavage or AFG3L2 regulates another protease that 
cleaves OMA1. 
To individuate the right hypothesis we co-transfected Afg3l2 ko MEFs with OMA1-
HA and AFG3L2-myc or its proteolytic inactive mutant AFG3L2-E575Q-Myc and 
we evaluated both OPA1 and OMA1 processing. The absence of AFG3L2 induces 
the processing of OPA1 towards the short forms as previously shown (Ehses et al., 
2009; Maltecca et al., 2012) and the accumulation of OMA1 60 kD band. The 
overexpression of AFG3L2 induces a slight increase in the amount of OPA1 L1 band 
indicating that the overexpression of AFG3L2 is able to restore the physiological 
processing of OPA1 and, at the same, to induce an increase in the amount of the 40 
kD OMA1 band. The overexpression of the proteolytic inactive form of AFG3L2 is 
not able to restore OMA1 processing, showing that AFG3L2 is involved in OMA1 
initial processing (Fig. 12A). To verify if AFG3L2 directly cleaves OMA1 or it 
activates other proteases, we explored a possible physical interaction between the two 
proteins by co-immunoprecipation (CoIp) studies. To stabilize the interaction we 
decided to use AFG3L2-E575Q-Myc, which is still capable of substrate binding but 
lacks proteolytic activity (Atorino et al., 2003) and, therefore, can be used as a trap to 
identify short-lived substrate proteins . With this approach we immunoprecipitated 
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AFG3L2 and identified OMA1 in the CoIp lane and the same result was obtained 
with the reverse approach (Fig. 12B). This result suggests that AFG3L2 directly 
performs its action on OMA1 and not through the involvement of other proteases.  
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Figure 12: AFG3L2 directly interacts with OMA1  
(A): Immunoblot analysis of total extracts, from Afg3l2 MEFs co-transfected with OMA1-HA, E.V. 
and AFG3L2-MYC or AFG3L2-E575Q-MYC detected with the indicated antibodies.( B): Co-
immunoprecipitation of AFG3L2 with OMA1in HeLa cells after over-expression of OMA1-HA, 
AFG3L2-E575Q-MYC or E.V. detected with the indicated antibodies. I= input; P= pre-clearing; 
F=flow-through 
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OMA1 processing from 60 kD to 40 kD occurs by a trimming mechanism  
 
Clarified the interaction between OMA1 and AFG3L2 we wanted to identify the 
hypothetical proteolytic consensus sequence recognized by the m-AAA to better 
characterize its general processing activity. To achieve this result we followed four 
parallel approaches.  
1. We performed a BLAST analysis between OMA1 murine amino acids 
sequence and MrpL32 sequence. MrpL32 (the only known substrate of the m-
AAA in mammals) is processed by the m-AAA protease in position 78 
(Alanine) (Nolden et al., 2005). OMA1 alanine in position 171 aligned with 
MrpL32 alanine in position 78. We hypothesised that this could represent a 
consensus sequence for the m-AAA proteases. To verify it, we decided to 
remove only the amino acid 171 and or the proximal ones. We generated 
deleted mutants: OMA1-Δ169-HA // OMA1-Δ170-HA// OMA1-Δ171-HA// 
OMA1-Δ169-172-HA (Fig. 13A); 
2. Using I-TASSER platform (Roy et al., 2012) we generated a 3-D protein 
prediction structure of OMA1 to individuate a predicted hydrophilic region 
theoretically more accessible for AFG3L2. With this strategy we detected a 
hydrophilic loop of eight amino acids from 173 to 180. We removed them 
generating the following mutants: OMA1-Δ173-176-HA// OMA1-Δ175-178-
HA// OMA1-Δ177-180-HA (Fig. 13B); 
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3. Using second structure prediction toll (PredictProtein Platform) (Yachdav et 
al., 2014) we individuated the first alpha helix domain (amino acid 144-157) 
to verify whether the m-AAA complexes activity could be influenced by this 
first hydrophobic region. We removed these amino acids generating: OMA1-
Δ147-149-HA// OMA1-Δ150-152-HA// OMA1-Δ153-155-HA// (Fig. 13C); 
4. We immunoprecipitated OMA1-HA to detect by MS/MS analysis the first 
amino acid of the N- terminus of OMA1 40 kD. 
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Figure 13:  identification of putative OMA1 40kD cleavage sites. 
(A) Blast alignment between OMA1 and MrpL32 amino acid sequences. (B) OMA1 third structure 
prediction. In the insert is represented the hydrophilic region identified as possible cleavage site. (C) 
OMA1 second structure prediction; arrow indicate the first α-helix hypothetical involved in OMA1 40 
generation. red squares indicate α-helix, while purple squares indicate β-sheet.  
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Sites detected with the first three approaches was mutagenized by deletion of 1, 3 or 4 
amino acids to remove the possible m-AAA consensus sequence and induce the 
accumulation of the 60 kD form. We generated 10 deleted mutants but they were 
correctly processed to generate the 40 kD form (Fig. 14 A-B). We concluded that the 
m-AAA proteases do not recognize a proteolytic consensus sequence. 
MS/MS analysis of immunoprecipitated OMA1 40 kD revealed that the N-term 
amino acid is the alanine in position 140, confirming recently published results by 
Baker and colleagues (Baker et al., 2014). From this information we decided to 
remove 53 amino acids between the predicted mitochondrial leader sequence and the 
first amino acids of OMA1 40 kD sequence. We generated OMA1 Δ92-144-HA; this 
mutant encodes for a protein of 50 kD and it is processed as the wild type to generate 
the 40kD form (Fig.14C). We concluded that the m-AAA proteases do not recognize 
a proteolytic consensus sequence. 
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Figure 14: the m-AAA proteases do not recognize a 
proteolytic consensus sequence. 
(A-B) Immunoblot analysis of total extracts from HeLa 
cells transfected with OMA1-HA, with several deleted 
mutants and. E.V. Soluble (S) and insoluble (I) fractions 
were loaded and then proteins were detected with the 
indicated antibodies. FL= full length. 
(C) Immunoblot analysis of total extracts from HeLa cells 
transfected with OMA1-HA, OMA1 Δ92-144-HA and 
detected with the indicated antibodies. 
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Interestingly, we always detected the presence of several intermediate specific bands 
between the major OMA1 60 kD and the 40 kD. These bands are OMA1 degradation 
products suggestive of a progressive trimming mechanism. This kind of degradative 
process was previously demonstrated for another m-AAA substrate, MrpL32 (Bonn et 
al., 2011). In fact, it was published that MrpL32 processing occurs immediately after 
its mitochondrial import; the m-AAA interacts with the N-term part of the protein and 
performs the processing which is stopped by the folding of a cysteine-containing 
domain of MrpL32 (Bonn et al., 2011). To verify if these intermediate bands are 
degradative products generated by a clipping mechanism mediated by the m-AAA 
complexes, we silenced AFG3L2 in HeLa cells and then we overexpressed a Stealth-
RNAi-insensitive AFG3L2-MYC construct or two proteolytic inactive AFG3L2 
mutants. These two mutants are respectively: AFG3L2-E575Q-MYC and AFG3L2-
E408Q-MYC. The first mutant is proteolytically inactive since the amino acid 
substitution E/Q prevents the Zn
+
-ion coordination that is fundamental for AFG3L2 
activity. The second mutant carries a mutation inside the Walker B domain, which is 
important since it hydrolyzes ATP to ADP to ensure the energy necessary for the m-
AAA complex activity. The ectopic expression of AFG3L2 induced the disappearing 
of the intermediate bands, which remained stable upon overexpression of the 
proteolytic inactive mutants ( Fig. 15). 
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Figure 15: The m-AAA complexes process OMA1 by a trimming mechanism. 
Immunoblot analysis of total extracts, from HeLa cells silenced for AFG3L2 and co-transfected with 
OMA1-HA or E.V plus, AFG3L2-MYC, AFG3L2-E575Q-MYC, AFG3L2-E408Q-HA RNAi stealth 
insensitive and detected with the indicated antibodies 
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60 kD OMA1 is dispensable for OMA1 processing 
Verified the mechanism that generates the OMA1 40 kD, we focused on 
understanding whether the 60 kD form could have an active role in OPA1 processing. 
Indeed, it was classified as a pre-pro-protein but without any experiment that 
excludes any role in OPA1 processing (Baker et al., 2014). Since the impossibility in 
the generation of an OMA1 uncleavable form, we decided to verify if the absence of 
the 60 kD could affect OPA1 processing. For this reason we transfected HeLa cells  
silenced for OMA1 with OMA1 Δ92-144-HA construct. OMA1 silencing was 
evaluated following OPA1 processing; in fact, in the absence of OMA1, it was 
demonstrated that S1 and S3 OPA1 processed bands disappear (Quiros et al., 2012) 
and we obtained the same result using Stealth RNAi against OMA1 (Fig.16B). In this 
KD condition, OMA1 Δ92-144-HA shows normal auto-proteolytic activity 
generating the 25 kD forms as the wild type protein (Fig. 16A). Moreover, it is able 
to restore OPA1 processing (Fig. 16B) and it is able to be efficiently activated when 
the mitochondrial membrane potential is altered (Fig. 16D). This deleted mutant, 
seems to be less prone towards the autocatalytic process (Fig. 16C), as another 
mutant described in previous paper (Baker et al., 2014), but nevertheless it is 
proteolytically active towards OPA1.  
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Figure 16: OMA1 60 kD is dispensable for OPA1 processing during physiologic condition. 
(A-B)Immunoblot analysis of total extracts from HeLa cells silenced for OMA1 and then transfected 
with OMA1-HA, OMA1 Δ92-144-HA RNAi stealth insensitive or E.V and detected with the indicated 
antibodies. (C-D) Immunoblot analysis of total extracts from HeLa cells silenced for OMA1 and then 
transfected with OMA1-HA, OMA1 Δ92-144-HA RNAi stealth insensitive or E.V. HeLa cells were 
subsequently  treated with FCCP 10 µM for 30 minutes and detected with the indicated  antibodies.. 
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OMA1 processing is dependent on mitochondrial membrane potential 
 
The importance of ΔΨ in the regulation of mitochondrial dynamics has been 
previously demonstrated (Song et al., 2007). In fact it was verified that the alteration 
of Δφ can induce mitochondrial fragmentation through OMA1-mediated OPA1 
processing (Ehses et al., 2009; Head et al., 2009). For this reason we investigated 
OMA1 processing upon the addition of an uncoupler drug (FCCP) at different time 
points. After 5’ minutes of FCCP treatment, the amount of the 40kD band is 
decreased by 95%, with the complete disappearing at 15’; the 60 kD form remains 
stable during all the time course. As expected, OMA1 proteolytic inactive mutant 
didn’t show any decrease in 40 kD amount since this mutant is not able to induce the 
auto-catalytic cleavage (Fig. 17A). On the other hand, the presence of the endogenous 
OMA1 allowed OPA1 processing after FCCP treatment (Fig 17A). OPA1 processing 
happens within the first 5 minutes of treatment, window of time in which the 95% of 
OMA1 is already activated (Fig. 17B).  
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Figure 17: OMA1 activity is related to OMA1 40 kD disappearing.  
(A-B) Immunoblot analysis of total extracts from HeLa cells transfected with OMA1-HA, OMA1 
E324Q-HA or E.V and treated for the indicated time points with FCCP 10 µM. Membrane was 
immunodecorated with the indicated antibodies. 
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We then wanted to understand how OMA1 is regulated when the stress is removed. 
To this end, we performed FCCP washout and we evaluated the reappearing of 
OMA1 40 kD band and the OPA1 long forms (L1 and L2) at different time points. 
When FCCP is removed, the 40 kD band reappears after 10 minutes, while the OPA1 
long isoform reappeared only after 6 hours (Fig. 18 A-B). This let us to conclude that 
OMA1 40 kD form is inactive and that OMA1 regulatory kinetic is extremely 
efficient with a very fast activation and deactivation mechanism.  
 
 
 
Figure 18: OMA1 40 kD band is stable in standard condition. 
(A-B) Immunoblot analysis of total extracts from HeLa cells transfected with OMA1-HA, OMA1 
E324Q-HA or E.V. Cells were treated with FCCP 10 µm for 30’ ; then the stress was removed and 
harvested at the indicated time points. Membrane was immunodecorated with the indicated antibodies. 
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OMA1 40 kD is a substrate of YME1L1 
 
Our data support the role of AFG3L2 in OMA1 processing. Nevertheless, the fact 
that OMA1 40 kD band remains visible in the absence of AFG3L2 suggests that 
another protease is involved in this mechanism. To test the hypothesis that YME1L1 
could be this second protease we silenced it in HeLa cells. The knock down of 
YME1L1 is not able to reduce the amount of the 40 kD band or to induce the 60 kD 
band accumulation while the double knock down didn’t induce difference. These data 
exclude a direct involvement of YME1L1 in 40 kD OMA1 generation and support 
the idea that the residual amount of the 40 kDa in condition of AFG3L2 depletion 
could derive from incomplete silencing efficiency in HeLa cell experiments or from 
the presence of AFG3L1 in MEF experiments or additionally another protease could 
be involved in OMA1 40 kD generation. This alternative mechanism can be 
overactivated in dramatic conditions such as the double knock down, masking the 
expected OMA1 60 kD accumulation. 
On the other hand, YME1L1 depletion is able to strongly increase the amount of 
OMA1 40 kD (Fig. 19A). The accumulation of the 40 kD band perfectly fits with the 
increased OMA1 activity on OPA1 in the absence of YME1L1; in fact it is known 
that the absence of YME1L1 induces mitochondrial network fragmentation through 
OPA1 processing in S1 mediated by OMA1 (Anand et al., 2014). This result 
highlights the role of YME1L1 in the regulation of OMA1 activity. To explain why 
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the absence of YME1L1 induces OMA1 40 kD accumulation we formulated four 
possible hypotheses:  
1) YME1L1 deficiency is able to increase the amount of the m-AAA complexes; 
2) YME1L1 overstimulates the m-AAA proteolytic activity; 
3) The absence of YME1L1 compromises OMA1 autocatalytic process; 
4) YME1L1 is directly involved in OMA1 40 kD degradation.  
The silencing of YME1L1 doesn’t increase AFG3L2 protein amount so we can 
exclude an increase in the m-AAA complex amount (Fig. 19A).  
Then, we evaluated the possible over proteolytic activation of the m-AAA complexes 
by assaying MrpL32 processing in YME1L1 KD condition. Nolden and colleagues 
demonstrated that MrpL32 is matured by the m-AAA protease and its absence 
induced the accumulation of Mrpl32 precursor form (Nolden et al., 2005). We 
silenced YME1L1, AFG3L2 or both genes and then we transfected a HA-tagged 
version of MrpL32 in HeLa cells. The absence of AFG3L2 induces an accumulation 
of MrpL32 full length protein as previously demonstrated (Nolden et al., 2005), while 
the absence of YME1L1 doesn’t increase the amount of MrpL32 mature product (Fig. 
19B). This data demonstrate that the proteolytic activity of m-AAA complexes is not 
over-activated in the absence of YME1L1.  
To test whether the absence of YME1L1 can affect the autocatalytic activation of 
OMA1 activity we evaluate the generation of OMA1 25 kD bands, to test the 
autocatalytic process, and the OMA1-mediated OPA1 processing to evaluate OMA1 
activation. We found that in the absence of YME1L1, the OMA1 25 kD bands is 
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generated and the amount of OPA1 S1 band increased (Fig. 19A); excluding that the 
absence of YME1L1 could impair OMA1 autocatalytic process.  
In order to verify if OMA1 40 kD band is a proteolytic substrate of YME1L1, we 
expressed wild-type YME1L1-MYC or YME1L-E543Q-Myc proteolytic inactive 
mutant in YME1L1 KD cells and valuated the amount of the 40kD band. Indeed, the 
overexpression of wild-type YME1L1-Myc in HeLa Cells silenced for YME1L1 led 
to a significant reduction in the levels of OMA1 40 kD, whereas transfection with 
YME1L-E543Q-Myc has no effect on the protein level (Fig. 19C). Putting together 
all these results we can assume that YME1L1 is directly involved in OMA1 
degradation. It represents the catabolic mechanism that the mitochondrial quality 
control uses to rapidly remove OMA1 40 kD. In this way, OMA1 accumulation is 
avoided and the consequent mitochondrial network fragmentation caused by OPA1 
over processing prevented. 
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Figure 19: OMA1 402 kD band is a substrate of the i-AAA complexes. 
(A): Immunoblot analysis of total extracts from HeLa cells silenced for AFG3L2, YME1L1 or both 
and then transfected with OMA1-HA or E.V and detected with the indicate antibodies. Quantification 
of the 60 and 40 kD band on β-tubulin after silencing of AFG3L2, YME1L1 or both the proteins. (B): 
Immunoblot analysis of total extracts from HeLa cells silenced for AFG3L2, YME1L1 or both and 
then transfected with MRPL32-HA or E.V and detected with the indicate antibodies. 
(C):Immunoblot analysis of total extracts from HeLa cells silenced for YME1L1 and then co-
transfected with OMA1-HA and YME1L1-MYC, YME1L1-E543Q-MYC or E.V and detected with 
the indicate antibodies. 
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DISCUSSION 
SCA 28 is a novel form of autosomal dominant cerebellar ataxia, characterized by 
gait difficulties, nystagmus, ophtalmoparesis and hyperreflexia. Many SCA28-
causing mutations were discovered in the last years in the AFG3L2 gene. This gene 
codifies for a mitochondrial protease of the inner membrane belonging to the AAA-
protein family that can assemble into homo-oligomers and hetero-oligomers with 
paraplegin forming the m-AAA complex. This complex is involved in protein quality 
control of the inner membrane and mediates chaperone-like activity on respiratory 
chain complexes and perform proteolytic maturation of substrates.  
The animal model which recapitulates most features of SCA28 patients is an Afg3l2 
haploinsufficient mouse. It displays defects in motor coordination and balance due to 
PCs degeneration. Mutant PCs show increased electron density and condensed 
cytoplasm and nucleus but no signs of apoptotic bodies. These features are peculiar of 
dark cell degeneration (DCD) that is characteristic of excitotoxic injury. In the 
SCA28 model this type of degeneration originates for the first time from 
mitochondrial dysfunction. Indeed, histological studies on the cerebellum of mice 
Afg3l2 heterozygous show dramatic defects in mitochondrial morphology and cristae 
organization and biochemical investigations revealed reduced activity of the 
respiratory chain. Mitochondrial phenotypes precede PC-DCD, demonstrating the 
mitochondrial origin of the degeneration. 
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We hypothesized that the pathological mechanism at the basis of PC-DCD in SCA28 
mice involves defective Ca
2+ internalization in mitochondria as a triggering event. 
This can in turn cause alteration of Ca
2+
 homeostasis and pathological accumulation 
of Ca
2+
 in Afg3l2 mutant PCs in condition of normal glutamate stimulation, thus 
mimicking exitotoxic-mediated DCD. Indeed, it is well known that mitochondrial 
Ca
2+
 buffering has a key role in the regulation of cellular Ca
2+
 homeostasis, especially 
in neurons. 
So, the aim of this thesis is focused on the clarification of the relationship between 
mitochondrial dysfunction and DCD. In particular I focused my research work on two 
aims: the analysis of mitochondrial morphology and mitochondrial Ca
2+
 buffering in 
the absence of AFG3L2 and the molecular mechanisms that cause mitochondrial 
fragmentation in the absence of AFG3L2. 
SCA28 patients carry heterozygous mutations and haplo-insufficency is the 
mechanism of the disease; therefore Afg3l2 heterozygous cells should represent the 
correct model to study SCA28. However, we couldn’t find any alteration in 
mitochondrial Ca
2+
 buffering and morphology in Afg3l2 heterozygous cells (MEFs 
and PCs) compared to wt. This could be explained by the fact that, the cell lines were 
derived from E15 embryo (MEFs) or P0 (PCs) mice while, the mitochondrial defects 
appear only at 4 months in SCA28 mice model, Indeed, up to 4 months Afg3l2 
heterozygous cells and wild type have the same behavior. In the light of these 
considerations and since it’s very difficult to model neurodegeneration in vitro, we 
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decided to use Afg3l2 ko cells to mimic in vitro the effect of the haploinsufficient in 
vivo.  
The morphometric analysis of the mitochondrial network in MEFs disclosed that the 
absence of AFG3L2 induces an evident network fragmentation compared to Afg3l2 
wt and heterozygous MEFs, which maintained a tubular network organization.  
We observed that mitochondrial fragmentation in Afg3l2 ko cells reduces the volume 
of individual mitochondrial particles without changing the total volume of the 
organellar network. As a direct consequence, a fraction of mitochondria in Afg3l2 ko 
cells lose their link to the ER and result positioned at a higher distance from the Ca
2+
 
source, failing to match the MCU-activation needs (Rizzuto et al., 1998) and 
therefore remaining without substantial [Ca
2+
]m rises. Moreover, studies have shown 
that Ca
2+
 entering mitochondria can spread and equilibrate rapidly within the matrix 
along large and tubular, but not fragmented organelles. In fact, the small size of 
mitochondrial particles in a fragmented network and the consequent lack of matrix 
connectivity limit the proper diffusion of the Ca
2+
 wave and increases the 
heterogeneity of mitochondrial Ca
2+
 responses (Frieden et al., 2004) (Szabadkai et al., 
2004). These phenomena together account for the overall reduction in the 
mitochondrial Ca
2+ 
load in Afg3l2 ko cells.   
Heterozygous and homozygous mutations in AFG3L2 cause neurodegeneration that 
mostly involves PCs in the cerebellum and results in ataxia (Di Bella et al., 2010; 
Pierson et al., 2011). The fact that cerebellum is more sensitive to AFG3L2 
Discussion  
132 
 
dysfunction compared with other neuronal tissues can be explained by the high 
expression of this gene in PCs (Di Bella et al., 2010), but also with the special 
requirement of mitochondrial functionality by PCs. These are indeed unique neurons 
with very large and highly branched dendritic trees which receive only glutamate 
excitatory synaptic input from a single climbing fiber and from ~200.000 parallel 
fibers. They are therefore exposed to high Ca
2+
 influxes due to glutamatergic 
stimulation of both mGluR1 and AMPA receptors (Ito, 2002), moreover they need a 
more precise control of Ca
2+
 homeostasis compared to other neurons, implying a 
higher Ca
2+
 buffering power. For such reasons, mitochondria play a pivotal role in 
maintaining Ca
2+
 homeostasis in PCs by direct uptake of Ca
2+
 and, also, by providing 
ATP to pump Ca
2+
 across membranes. We therefore hypothesize that the inefficient 
buffering and shaping of the Ca
2+
 waves operated by mutant mitochondria provokes a 
local increase in [Ca
2+
]c and that this, in chronic conditions like as in associated 
diseases, triggers PCs degeneration. 
To verify this hypothesis, and considering the limitation represented by non- 
excitable and non-polarized cells such as fibroblasts, we cultured primary PCs and we 
tested in these cells if the proposed mechanism of pathogenesis for SCA28 was 
corrected.  
EM analysis revealed dramatic alterations of organellar ultrastructure in mutant PCs, 
showing mitochondria with vesiculation of the inner membrane or completely 
swollen. In addition to these ultrastructural defects, Afg3l2 ko PCs show increased 
Discussion  
133 
 
mitochondrial network fragmentation and faulty mitochondrial distribution in the 
dendritic tracks. In particular, we observed that the volume of mitochondria 
associated to dendrites is reduced in the absence of AFG3L2, indicating a skewed 
distribution of mitochondria toward the cell soma. 
We directly measured [Ca
2+
]m in primary PCs after KCl induction and we found it 
markedly reduced in Afg3l2 PCs, in line with morphological alteration. Thus, such 
data allowed us to propose a pathogenetic mechanism in which loss and 
haploinsufficiency of Afg3l2 causes fragmentation of mitochondria, which weakens 
the mitochondrial buffering of Ca
2+
 elevations in the soma. This scenario is worsened 
in mutant dendrites due to mitochondria underpopulation, too.  
It’s also conceivable that reduced ATP production by mutant mitochondria can 
locally slow down the kinetic of Ca
2+
 pumps, affecting the extrusion of Ca
2+
 from the 
cytosol into the ER and across the plasma membrane in dendrites. 
All these data demonstrated that the alteration of mitochondrial dynamics is the cause 
of defective mitochondrial Ca
2+
 handling in Afg3l2 mutant cell lines, providing a 
direct molecular link between mitochondrial defect and dark cell degeneration of Pcs 
(Model A).  
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Model A 
Mutation of Afg3l2 causes fragmentation of mitochondria, which weakens the mitochondrial Ca
2+
 
buffering increasing the [Ca
2+
]cyto and finally inducing DCD. This scenario is worsened in mutant 
dendrites due to mitochondria underpopulation, too. 
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After demonstrating the mitochondrial network alteration, we focused on disclosing 
the molecular mechanism that causes mitochondrial fragmentation in the absence of 
Afg3l2. 
Mitochondrial network fragmentation can be caused by an increase in the rate of 
fission events or a decrease in fusion. We excluded the first hypothesis since DRP1 
didn’t result relocalized on the mitochondrial surface in Afg3l2 ko MEFs. This means 
that the mitochondrial fission machinery is not over-activated by the absence of 
AFG3L2 but there should be an alteration in the fusion mechanism. To test this 
hypothesis we evaluated OPA1 processing demonstrating that mutant Afg3l2 MEFs 
and neuronal tissues shod an accumulation of the short OPA1 forms with the parallel 
decreased of OPA1 long forms.  
These data demonstrate that Afg3l2 ko cells have a strong defect in the inner 
membrane fusion machinery, by losing OPA1 long forms. OPA1 long forms are 
fundamental to maintain the correct cristae tightness and the consequent tubular 
structure of the network. How the lack of OPA1 long forms and the increase in OPA1 
short forms could induce mitochondrial fragmentation is not known. We can 
speculate that short OPA1 isoforms may stimulate membrane fission and contribute 
to the coordination of mitochondrial fusion and fission. Indeed, it is conceivable that 
short OPA1 isoforms interact with the fission machinery at the OM or is involved in 
IM fission. A stimulatory role of short OPA1 isoforms in mitochondrial fission may 
be crucial under stress conditions or upon induction of apoptosis and/or mitophagy 
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and is therefore likely to be of particular importance for mitochondrial quality 
control. 
The enhanced OPA1 cleavage in the absence of AFG3L2 was mediated by OMA1 as 
previously demonstrated (Ehses et al., 2009; Head et al., 2009). OMA1 full length 
proteins weight 60 kD but it was proposed that the active form is a shorter form 
around 40 kD. Up to date, nothing is known about the protease that mediates the  
60/40 kD cleavage. Head and colleagues proposed YME1L, AFG3L2 and paraplegin 
as possible proteases involved in this mechanism and they tried to evaluate OMA1 
60/40 kD processing after siRNA experiment. They failed to observe any difference 
in OMA1 processing after silencing of each of these genes, but at the same time 
declaimed that there may still be present residual proteases in their experiments as 
consequence of low silencing efficiency (Head et al., 2009). This limitation prevented 
them to give a definitive conclusion. 
Moreover, in the same work the authors noticed that OMA1 60 kD form was 
detectable only after treatment with an uncoupler drug such as CCCP. Since this 
accumulation coincides with OPA1 processing, they proposed that the OMA1 60-kD 
form was the active species and that the 40-kD band was a breakdown product. These 
observations lead to a model in which OMA1 activity is normally attenuated by high 
rates of turnover. This turnover was slowed when mitochondria lose membrane 
potential or matrix ATP, making it possible to cleave OPA1 protein.  
However, other groups rejected this idea giving to the 40 kD the role of the active 
form. In particular Baker and colleagues demonstrated that the OMA1 40 kD is the 
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active one on OPA1 and this is the one building OMA1 complex; nevertheless they 
never provide experiments that formally excluded OMA1 60 kD as the active form, 
even because they weren’t able to detect the full length form by Western blot.  
In both the papers authors were obliged to use an OMA1 tagged version since an 
antibody finely working in Western blot is not still available. The two groups used 
two different tags for OMA1; Head used HA-tag, while Eshes and Baker used a Myc 
tag. This difference could be a possible explanation to interpret the reason why Ehses 
and Baker didn’t detected the 60 kD form. It is not known if the HA-tag could 
stabilize the half-life of OMA1 or otherwise if the Myc tag could increase its 
degradation, but in either the case the Myc or HA OMA1 versions maintain their 
pivotal role on OPA1 processing. Since OMA1-HA allows following the 60 kD and 
the 40 kD forms we decided to use this tag version of the protein for our study.  
Starting from the information obtained in the first part of my thesis and from the 
above mentioned published works, we decided to investigate on OMA1 60/40 kD 
processing to understand whether OMA1 is directly regulated by AFG3L2 itself or 
indirectly by the respiratory deficiencies mediated by the loss of AFG3L2.  
We clarified that the first step (60/40 kD) of OMA1 maturation occurs inside the 
mitochondria and not in the cytosol, since the mitochondrial import inhibition 
prevented OMA1 40 kD formation. These results indicate that the processing occurs 
inside the mitochondria, in line with previous paper (Head et al., 2009). These 
experiments allowed us to clarify that OMA1 doesn’t have a canonical leader 
sequence cleaved by mitochondrial processing peptidase (MPP). OMA1 
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mitochondrial leader sequence was identified in different prediction software but we 
weren’t able to discriminate between the precursor and the 60 kD form. We didn’t 
observe OMA1 precursor form even combining the mitochondrial import inhibition 
to the proteasomal inhibition using MG132. This finding is even supported by 
experiments of Head and colleagues which demonstrated, with an in vitro system, 
that OMA1 is imported in the mitochondria also when the mitochondrial membrane 
potential is altered or when ATP is depleted. This could not be possible for proteins 
imported by classical TOM-TIM import machinery (Schmidt et al., 2010). In fact, it 
is known that alteration of the mitochondrial membrane potential or ATP depletion 
are sufficient to inhibit the mitochondrial import mechanism mediated by TOM-TIM 
complexes (Schmidt et al., 2010). 
Moreover, OMA1 was not detected among the proteins identified in yeast TIM23-
core complex interactome (Mehnert et al., 2014). Future studies will clarify if OMA1 
is imported by an alternative known or unknown pathway. 
By combining digitonin extractions with trypsin digestions we determined in which 
sub-mitochondrial compartment OMA1 40 kD is generated. OMA1 60 kD behaves 
like Mitofusin 2, an integrated outer membrane protein, and it is degraded by trypsin 
alone. This could be explained in two ways. In the first case OMA1 60 kD is only 
associated to the mitochondrial outer membrane as a pre-protein and so it is digested 
by trypsin; in the second case, trypsin digested the C-term tail of OMA1 60 kD that is 
still outside the mitochondria while the rest of the protein is going through the outer 
membrane during the import. Since the OMA1 60 kD form was detected as an 
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integral membrane protein (Head et al., 2009) it is reasonable to speculate that the 
right hypothesis is the second one. However, OMA1 40 kD was accessible to trypsin 
and disappeared only in the presence of digitonin. OMA1 40 kD showed the same 
trypsin sensibility of TIM23 indicating that OMA1 40 kD must have at least one 
transmembrane domain. The C-terminus of OMA1, and OMA1 M48 cleavage 
domain, must be exposed toward the IMM since OPA1 cleavage site is localized in 
this sub-mitochondrial localization. Considering our aim of disclosing the proteases 
involved in OMA1 60/40 kD processing, these results allowed us to focus our 
attention on the mitochondrial proteases localized in the inner mitochondrial 
membrane. 
We observed OMA1 60 kD form accumulation using metallopeptidase inhibitors. We 
used this information and the sub-mitochondrial localization to screen several 
proteases databases, finally identifying 4 possible proteins involved in OMA1 60/40 
kD processing: OMA1 - paraplegin - AFG3L2 and YME1L1. 
Interestingly, these proteins are the same previously excluded by Head and colleagues 
(Head et al., 2009) but, since their data were not shown in the paper, we decided to 
investigate and verify if OMA1 60/40 kD processing is mediated by one of these 
proteins.  
OMA1 itself was the first protein that we tested; in order to do it we used a 
proteolytic inactive mutant (OMA1-E324Q-HA). Transfection of this mutant in HeLa 
cells didn’t induce an accumulation of the 60 kD form, while we noticed the 
disappearing of the 25 kD bands. This experiment, even if performed in the presence 
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of the endogenous one, allowed us to conclude that OMA1 is able to digest itself 
from the N-term generating the 25 kD forms, but it is not involved in the generation 
of the 40 kD form. This result is supported by an experiment performed by Head and 
colleagues who transfected the proteolytic inactive mutant in OMA1 silenced cells. 
They performed this experiment with a different purpose but the Western blot showed 
the presence of the 40 kD band when the proteolytic inactive mutant was expressed 
(Head et al., 2009) thus confirming, our result. Interestingly, when we overexpressed 
OMA1-E324Q-HA in HeLa cells we didn’t inhibit OMA1-mediated OPA1 
processing.  This result leads us to conclude that the proteolytic activity of OMA1 is 
extremely efficient since the endogenous OMA1 is able to perform OPA1 processing 
even when the proteolytic inactive form is overexpressed. In this condition, OMA1 
complexes are theoretically formed by a high percentage of proteolytic inactive 
subunits and, therefore, the proteolytic activity should be impaired. On the contrary, 
OMA1 mediated OPA1 processing wasn’t affected indicating that the endogenous 
form is sufficient to perform correctly all its proteolytic activity. 
We also excluded paraplegin in the generation of OMA1 40 kD form. In fact, 
transfecting OMA1-HA in SPG7-/- human immortalized fibroblasts we didn’t find 
any alteration in OMA1 processing. This is in line with unaltered OPA1 processing in 
the absence of paraplegin (Ehses et al., 2009).  
A possible explanation for this result is that paraplegin only exists in hetero-
oligomeric complexes together with AFG3L2, whose alterations in fibroblasts don’t 
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affect mitochondrial dynamics. The possible involvement of paraplegin in OMA1 
processing should be studied in cells where paraplegin mutations induce 
mitochondrial defects as spinal and peripheral axons (Ferreirinha et al., 2004). 
 Testing OMA1 processing in Afg3l2 ko fibroblasts led us to observe an accumulation 
of OMA1 60 kD form compared to wild type MEFs and a decreased of the 40 kD 
form. This result was also observed in HeLa cells silenced for AFG3L2. In both the 
conditions we also detected an increased OMA1 mediated OPA1 processing and the 
consequent mitochondrial network fragmentation that we previously reported.  
To explain how the absence of AFG3L2 induces OMA1 60 kD accumulation, we 
formulated four hypothesis: 
AFG3L2 is the protease that cleaves OMA1 60 kD. Thus generating the 40 kD 
form. 
AFG3L2 regulates another protease that exerts the above mentioned function.  
AFG3L2 impairment produces the mitochondrial stress that drives to OMA1 
60/40 kD processing  
The absence of AFG3L2 causes a defect in the import of OMA1. 
Our experiments support the first hypothesis showing that AFG3L2 is the protease 
that mediates OMA1 60/40 kD cleavage. After demonstrating a physical interaction 
between AFG3L2 and OMA1, we performed by co-immunoprecipitation between 
OMA1-HA and the proteolytic inactive mutant AFG3L2-E575Q-MYC. To achieve 
the results, given the fast kinetic of a proteolytic event, we needed to optimize the 
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interaction between AFG3L2 and OMA1. Moreover, the unavailability of a specific 
antibody against OMA1 working in Western blot, prevented us to perform the Co-Ip 
experiment in endogenous conditions. We confirmed the direct proteolytic role of 
AFG3L2 in OMA1 processing by a complementary approach: in fact, the 
overexpression of AFG3L2-Myc was able to restore OMA1 60/40 kD processing and 
partially OPA1 processing, while the overexpression of the proteolytic inactive 
mutant (AFG3L2-E575Q-Myc) wasn’t able to do it. This result demonstrates that 
AFG3L2 is the protease involved in OMA1 40 kD generation. The clarification of the 
relationship between AFG3L2 and OMA1 is important because introduces a new 
pathway in the regulation of mitochondrial dynamics. In fact, it is conceivable that 
OMA1 interacts with AFG3L2 immediately after its import in an unfolded 
conformation. At this point the interaction should generate the OMA1 40 kD form 
that will be OMA1 oligomeric unit of OMA1 complexes.  
However, the increased OPA1 processing and the decreased amount of OMA1 40 kD 
band that we found in the absence of AFG3L2 are difficult to reconcile with the 
model that indicates the 40 kD band as the active OMA1 form. A possible 
explanation could be that the real active OMA1 form is not the 40 kD, but one of its 
cleavage products. Indeed, in a previous paper, a second form of OMA1 slightly 
smaller than OMA1 40 kD form was detected using OMA1-specific antibodies 
(Baker et al., 2014). This smaller form is generated by an autocatalytic processing 
that involves the last C-term amino acids of the protein, causing the disappearing of 
the HA tag and therefore making it not visible by Western blot. It’s conceivable that 
Discussion  
143 
 
the absence of AFG3L2 impairs the kinetic of OMA1 60kD to 40 kD conversion 
leading to the accumulation of the 60 kD, but at the same time the environmental 
stress caused by the absence of AFG3L2 (ATP depletion, increased ROS production), 
can activate OMA1 auto-catalytic cleavage, leading to a reduction of the 40 kD 
OMA1 and, possibly, to increased amount of the smaller form of OMA1, which is the 
one really acting on OPA1. In support to this, reintroduction of AFG3L2 in Afg3l2 ko 
cells is able to reduce the stress and to restore the physiological condition, stopping 
OMA1 C-term auto-cleavage activation resulting in OMA1 40 kD band increase. In 
addition to the clarification of OMA1 60/40 kD mechanism, these data have an 
additional value because they identify a new mammalian substrate of AFG3L2. Up to 
date only MrpL32 was demonstrated to be matured by the m-AAA complexes 
(Nolden et al., 2005). Our data reinforce the idea that the m-AAA complexes can be 
involved in the maturation of several other proteins with different activity inside the 
mitochondria. 
The N-Term of MrpL32 and OMA1 didn’t show a high sequence homology, leading 
us to exclude the presence of a conserved consensus sequence recognized by the m-
AAA, but they showed the same peculiar maturation system. In fact, these two 
proteins are processed by a proteolytic trimming. This mechanism was demonstrated 
in yeast by Bonn and colleagues (Bonn et al., 2011) for MrpL32; they discovered that 
the processing of the ribosomal subunit MrpL32 by the m-AAA protease depends on 
the folding of MrpL32 rather than on the specific recognition of the cleavage site. The 
m-AAA protease binds to N-term regions of newly imported MrpL32 and initiates 
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proteolysis, which is halted by a tightly folded, cysteine-containing domain of 
MrpL32. This sequence is not present in OMA1, but the trimming mechanism is 
conserved for OMA1 maturation. We observed the presence of degradative 
intermediates bands between the 60 kD and the 40 kD forms particularly when we 
silenced AFG3L2 in HeLa cells. These bands were degraded when AFG3L2 was 
expressed in silenced cells, while they remained stable when the proteolytic inactive 
mutants were expressed. To confirm this mechanism we generated 10 mutants with 
deletion of 3 or 4 amino acids in different OMA1 regions identified as m-AAA 
possible target sequences by bioinformatics prediction tools; but in any case the m-
AAA complexes were able to process OMA1. To have a further confirmation we 
generated a mutant with a deletion of 53 amino acids upon the N-term amino acid 
mapped in position 140 (OMA1-Δ92-144-HA) and even this mutant was processed 
by a trimming mechanism. Our experiment demonstrated that the N-term of OMA1 
interacts with the m-AAA complexes and it is processed until the hydrophobic 
domain around the amino acid in position 140. It is reasonable to hypothesize that the 
m-AAA complexes halt OMA1 degradation in this position because this area contains 
6 leucines. In fact, it was previously demonstrated that m-AAA proteases were not 
able to dislocate intermembrane protein from the inner mitochondrial membrane 
when the transmembrane domain of this protein had at least 5 leucines (Botelho et al., 
2013). 
Although all these mutants failed to show a common consensus sequence, OMA1 
Δ173-176-HA mutant displayed an interesting behaviour. In fact, the deletion of these 
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4 amino acids induced the inhibition of the auto-catalytic processing identifying this 
area as a key regulatory domain for the proteolytic activity of OMA1 itself. This 
result is in line with what was proved by Baker and colleagues which individuated the 
lysines 176-177-181-185-186-188 as sensor domain, that induces conformational 
changes in OMA1 upon membrane depolarisation leading to its activation and 
autocatalytic turnover (Baker et al., 2014). 
Future studies will be able to tell whether all the lysine containing sequence is 
fundamental for OMA1 activity or only the lysine in position 176. Clarification of 
this point could give a new strategy to modulate OMA1 activity and could be 
important to design therapeutic strategies in disorder as SCA28, caused by OMA1-
mediated mitochondrial network fragmentation. 
Another important point to be clarified is the role of OMA1 60 kD. As reported 
before in this discussion, recent papers demonstrated that the OMA1 active form is 
the 40 kD clipped off the last 30 amino acids (Baker et al., (Zhang et al., 2014); but 
once again a possible role of OMA1 60 kD on OPA1 processing, especially during 
stress condition when it accumulates (Head et al., 2009), was never demonstrated. 
Transfecting OMA1 mutant Δ92-144 in OMA1 silenced HeLa cells we observed that 
OPA1 processing was rescued demonstrating for the first time that the 60 kD form is 
dispensable during physiological conditions. The situation was less clear in the 
presence of a mitochondrial stress condition, such as Δφ depletion. In this situation 
OPA1 is processed but with a lower efficiency compared to the sample expressing 
OMA1- wt. This indicates that the deletion of the amino acids sequence 92-144 could 
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alter the structure of OMA1 complexes making it less responsive to the OMA1 
activation. This result was unexpected since the mutant OMA1 Δ92-144-HA has all 
the theoretical amino acid sequence of OMA1 40 kD. This result could be the base of 
future studies in order to better clarify which are OMA1 monomers that will build the 
active complexes.  
However, coming back to the initial role of OMA1 60 kD, the impossibility to 
generate an uncleavable form keep this question unsolved; and this should be taken in 
account especially when the role of OMA1 is studied in diseases that could induce 
OMA1 activation.  
OMA1 regulatory activator mechanism has been widely described in previous paper 
(Baker et al., 2014) indicating the autocatalytic process at the C-term as a pivotal step 
for the activation of the proteolytic activity, describing the fundamental domain at 
OMA1 N-term. However, few information were showed about the time of activation 
or inactivation of the proteins. We demonstrated that OMA1 is immediately activated 
after few minutes of stress induction, since OPA1 long forms are quickly processed 
and OMA1 40 kD band disappeared in Western blot since the autocatalytic activation 
removes the HA tag as previously argued. Interestingly, also the inactivation kinetic 
of OMA1 is extremely fast, in fact, we could observe the reappearing of the inactive 
40 kD form when the physiological condition is restored. This behavior underlines 
the importance of OMA1 in mitochondrial dynamics and in particular it showed a 
very efficient regulatory system which is able to active or to inactive OMA1 
depending on the cellular needs. 
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We demonstrated that the i-AAA complexes are not involved in OMA1 60/40 kD 
processing but, interestingly we observed that the absence of the i-AAA induced an 
accumulation of OMA1 40 kD. This indicates that the i-AAA proteases mediates 
OMA1 40 kD degradation. This accumulation could be explained by two different 
hypothesis: in the first case the i-AAA protease degrades OMA1 40 kD form, before 
its oligomerization in OMA1 complexes; in the second hypothesis i-AAA is involved 
in the turnover of OMA1-complexes. Our data are in contrast with Baker and 
colleagues (Baker et al., 2014) recently published data, which didn’t observe 
alteration in OMA1 40 kD amount after YME1L1 silencing. Our rescuing experiment 
excludes that our data could derive from a technical bias and we thought that Baker 
and colleagues failed to detect OMA1 40 kD accumulation for a matter of tag. As 
discussed before, the Myc tag, used in their experiment, could decrease the stability 
of the protein with a consequent increase in its degradation. This could finally mask 
the effect mediated by the absence of i-AAA since OMA1-Myc has already degraded 
with a fast kinetic. 
These results demonstrated for the first time that the m-AAA and the i-AAA 
complexes work coordinately in the regulation of OMA1. These data suggest that the 
two AAA complexes could work together in the regulation of other proteins (Model 
B). In previous papers, it has been demonstrated that the absence of AFG3L2 
(Hornig-Do et al., 2012) or the absence of YME1L1 (Stiburek et al., 2012) induces an 
accumulation of proteins belonging to respiratory complex I. To clarify whether m-
AAA and i-AAA complexes specifically exert their chaperone like activity towards 
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complex I protein, acting through a coordinated action, would give a new perspective 
in the comprehension of diseases related to complex I defects (Fassone and Rahman, 
2012).  
Model B  
Physiological condition                                        Absence of YME1L1 
 
 
Absence of AFG3L2 
 
In physiological condition OMA1 full length interacts with AFG3L2 after mitochondrial import. This 
interaction will generate the pre-protein OMA1 40 kD. OMA1 40 kD is a substrate of the i-AAA 
protease avoiding its accumulation. 
When necessary, OMA1 40 kD is activated by auto-catalytic processing and this smaller form can 
cleave OPA1 in S1 producing OPA1 short forms indispensable for the mitochondrial fission. 
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When YME1L1 is absent OMA1 40 kD accumulates. This accumulation together with the stress 
caused by the absence of the i-AAA complexes induces OMA1 activation. OMA1 40 kD undergoes 
auto proteolytic activation, OPA1 is processed and the mitochondrial network fragments. 
 
When AFG3L2 is absent or mutated an unknown compensatory mechanism works to generate OMA1 
40 kD. The absence of m-AAA complex induces several stress events that are able to activate 
OMA1.OMA1 40 kD form undergoes auto proteolytic activation, OPA1 is processed and the 
mitochondrial network fragments 
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CONCLUSION AND PERSPECTIVES 
We studied the role of AFG3L2 in mitochondrial dynamics and mitochondrial Ca
2+
 
buffering in SCA28 pathogenesis. Our studies demonstrated that PCs degeneration in 
SCA28 model mice occurs as a consequence of defective Ca2+ buffering caused by 
mitochondrial network alterations. We found that Afg3l2 ko mitochondrial network is 
fragmented as result of OMA1-mediated OPA1 processing. OMA1 processing in 
Afg3l2 depleted cells is impaired: OMA1 60 kD accumulates, indicating that AFG3L2 
processes OMA1 by trimming the N-terminus tail of the protein. Moreover, we 
provided evidence that another unknown protease is involved in OMA1 processing 
when the m-AAA complex is absent or altered. In addition to the role of the m-AAA 
in OMA1 maturation, we found that the i-AAA complex also has a pivotal role in the 
OMA1 regulatory mechanism, disclosing for the first time a co-operative mechanism 
between the m-AAA and the i-AAA. 
The clarification of the relationship between mitochondrial dysfunction and 
Ca
2+
buffering alteration gives new important perspectives from a translational point 
of view. In fact, we have already demonstrated that when we recovered the 
mitochondrial morphology of Afg3l2 ko MEFs we also rescue the mitochondrial Ca2+ 
buffering defect (Maltecca et al., 2012). The data presented in this thesis on the causal 
link between mitochondrial morphology and the mitochondrial Ca
2+
 buffering in 
Afg3l2 ko PCs allowed us to hypothesize that rescuing mitochondrial morphology 
could prevent neurodegeneration in SCA28. Since pharmacological treatments able to 
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rescue mitochondrial morphology are not available yet, it was more reasonable to act 
through the glutamatergic system, thus helping the poor mitochondrial Ca
2+
 buffering 
capacity. 
According to this mechanism, our lab demonstrated that the SCA28 mice phenotype 
is fully rescued by halving the amount of metabotropic glutamate receptors 
(mGluR1). PCs express high levels of mGluR1 in the soma and in dendritic spines, 
and this receptor is essential for synapse plasticity and for motor coordination. The 
Afg3l2 heterozygous Grm1 heterozygous
 
double mutants mice display motor function 
and coordination in the normal range and degenerating PCs are remarkably reduced 
compared to Afg3l2 haploinsufficient mice. In parallel, our lab demonstrated that 
Afg3l2 haploinsufficient mice treated with a drug able to consistently increase the 
transcription levels of the astrocyte glutamate transporter EAAT2 (Rothstein et al., 
2005), showed a significant amelioration in motor function, coordination and PCs 
degeneration consequent to the reduced glutamatergic stimulation of PCs in Afg3l2 
heterozygous mice. (Maltecca et al., in press). 
An obvious perspective will be to test rescuing other cerebellar ataxia characterized 
by PC-DCD. Indeed, PC-DCD has been described in SCA2 (Kasumu and 
Bezprozvanny, 2012), SCA3 (Boy et al., 2010), SCA5 (Ikeda et al., 2006) and 
SCA7(Custer et al., 2006). SCA2 is caused by mutations in ataxin 2, SCA3 by 
mutations in ataxin 3, SCA5 by mutations in β-III-spectrin (SPTBN2) and SCA7 by 
mutations in ataxin 7. These are not mitochondrial proteins and the molecular 
mechanism inducing excitotoxicity doesn’t involve mitochondria. It has been 
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published that mutations in ataxin 5 and 7 induce increased glutamatergic stimulation 
with the consequent increment in the [Ca
2+
]c. The genetic and pharmacological rescue 
demonstrated in our lab for SCA28 could be successful also for the treatment of these 
other forms of SCA.  
Furthermore, it has been published that high level of [Ca
2+
]c impacts on the 
mitochondrial network organization inducing fragmentation (Cribbs and Strack, 
2007). So, it will be striking to screen for new drugs able to induce mitochondrial 
fusion and to increase the Ca
2+
 buffering capability, and finally decrease [Ca
2+
]c. We 
have demonstrated that restoring the mitochondrial fusion is sufficient to rescue the 
mitochondrial Ca
2+
 alteration of a mitochondrial fragmented network (Maltecca et al., 
2012)  
From this point of view, this thesis can give another important starting point. In fact, 
we have disclosed the proteins involved in the regulation of OMA1 that directly 
impact on OPA1, the only protein actually involved in fusion and fission. 
Exogenously regulating OMA1 activity or modulating AFG3L2 or YME1L1 can 
deeply impact on diseases caused by mitochondrial dynamics alteration (Chen et al., 
2014). 
For this reason, future studies will be focused on the identification of possible post 
translational modifications (PTM) that could impact on the activity of these three 
proteins. In fact, in the last years, several works have demonstrated that several 
mitochondrial proteins undergo post translational modification inside the 
mitochondria. For example, it was recently demonstrated that OPA1activity is 
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regulated by acetylation/deacetylation processes mediated by SIRT3 (Samant et al., 
2014). Moreover, it was reported that paraplegin processing is regulated by AFG3L2 
tyrosine phosphorylation, although up to date it is still unknown which is the tyrosine 
kinase active in the intermembrane space (Almontashiri et al., 2014).Therefore  the 
same OMA1 or YME1L1 activity can be modulated by post translational 
modifications and the clarification of this point could give new perspectives for the 
treatment of diseases affected by mitochondrial dynamics alteration. 
As described in result and discussion, in the absence of the m-AAA proteases, OMA1 
60/40 kD processing occurred through an alternative pathway uncharacterized. So, 
parallel to the identification of possible PTM it will be very important to clarify 
which is (are) the alternative protease(s) involved in OMA1 generation when 
AFG3L2 is absent. The complete clarification of the pathway will provide new 
strategies to treat mitochondrial related diseases. From this point of view, it is very 
interesting to observe that mutations involving mitochondrial dynamics are often 
associated to neurodegeneration. This is explained by the pivotal roles of 
mitochondria in neurons. Neurons rely their energetic demand principally on 
mitochondrial ATP, so it is evident that alterations in mitochondria can immediately 
impact on neuron health. 
Moreover, the right localization of the mitochondria and the ATP production is 
fundamental to avoid neurodegeneration. In fact, it is particularly important that 
mitochondria are being transported to the peripheral dendrites to perform Ca
2+
 
buffering, but it is equally important to provide the sufficient ATP amount to fuel ion 
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pumps (Ca
2+
 + Na
+
/K
+
) on the plasma membrane and ER. This explains why even 
proteins involved in mitochondrial transport can induce neurological diseases 
(Nguyen et al., 2014).  
In the last years, the relationship between mitochondrial motility and dynamics, 
aimed several works demonstrating that the size of a mitochondrion have a direct 
impact on its mobility(Sheng and Cai, 2012). Indeed, interconnected mitochondrial 
tubules found in fission-deficient neurons are less efficiently transported to distal 
synapses, while it was demonstrated that DRP1 is required for delivering 
mitochondria to neuromuscular junctions (Verstreken et al., 2005). Conversely, 
mutation of a mitochondrial motor adaptor protein (Miro 1) results in mitochondrial 
fragmentation in addition to impaired motility. Moreover, neurons defective in Mfn2 
display reduced mitochondrial motility and altered mitochondrial distribution (Chen 
et al., 2007). Therefore, regulating mitochondrial trafficking directly affects their 
morphology. At the same time, changing mitochondrial fusion–fission dynamics 
impacts transport and distribution. This complex balance could be a partial 
explanation of the high sensitivity of PCs, compared to other neurons, towards 
mitochondrial defects. In fact, it has been shown that mutations in other fission/fusion 
mitochondrial proteins, as Drp1 or Mitofusin, induce PCs degeneration (Ranieri et al., 
2013). The high sensitivity of PCs to neurodegeneration when a mitochondrial 
dynamics protein is mutated is a matter of study. A possible explanation focuses the 
attention to the PCs unique architecture. In fact these cells have a very large dendritic 
tree and this implicates a continuous and massive post synaptic stimulation. As said 
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before, PCs are principally stimulated by climbing fibers which provide very 
powerful glutamatergic input to the proximal dendrites and cell soma. This implicates 
that the [Ca
2+
]c at the dendritic sites can reach even 1mM concentration and so, to 
avoid excitotoxicity, the Ca
2+
 buffering machinery must be perfectly working. When 
mutations in mitochondrial “fusion/fission” proteins occur, there is the consequent 
alteration in the mitochondrial shape, ATP production and localization that finally 
impact on the Ca
2+
 buffering. All these evidence explain why PCs are particularly 
sensitive compare to the other neurons to mitochondrial defects. The case of 
autosomal dominant optic atrophy (ADOA) caused by mutation in OPA1 is also 
interesting. In this disease the neurodegeneration involves the optic nerve, in 
particular the retinal ganglion cell whose architecture is very similar to the PCs and 
even in this case the neurodegeneration is associated to glutamate excitotoxicity. This 
further evidence suggests that mutations in mitochondrial dynamics proteins could 
preferentially affect branched neurons finally inducing excitotoxicity.  
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